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ABSTRACT 
 
Background. The extracellular promastigote and the intracellular amastigote stages alternate in the 
digenetic life cycle of the trypanosomatid parasite Leishmania. Amastigotes develop inside 
parasitophorous vacuoles of mammalian phagocytes, where they tolerate extreme environmental 
conditions. Temperature increase and pH decrease are crucial factors in the multifactorial 
differentiation process of promastigotes to amastigotes. Although expression profiling approaches for 
axenic, cell culture- and lesion-derived amastigotes have already been reported, the specific influence 
of temperature increase and acidification of the environment on developmental regulation of genes has 
not been previously studied. For the first time, we have used custom L. infantum genomic DNA 
microarrays to compare the isolated and the combined effects of both factors on the transcriptome.  
Results. Immunofluorescence analysis of promastigote-specific glycoprotein gp46 and expression 
modulation analysis of the amastigote-specific A2 gene have revealed that concomitant exposure to 
temperature increase and acidification leads to amastigote-like forms. The temperature-induced gene 
expression profile in the absence of pH variation resembles the profile obtained under combined 
exposure to both factors unlike that obtained for exposure to acidification alone. In fact, the 
subsequent fold change-based global iterative hierarchical clustering analysis supports these findings. 
Conclusions. The specific influence of temperature and pH on the differential regulation of genes 
described in this study and the evidence provided by clustering analysis is consistent with the 
predominant role of temperature increase over extracellular pH decrease in the amastigote 
differentiation process, which provides new insights into Leishmania physiology.   
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BACKGROUND 
 
The life cycle of the trypanosomatid parasite Leishmania is digenetic because it is developed 
in two distinct hosts. Promastigote is the extracellular stage and differentiates inside the gut of female 
phlebotominae sand-fly vectors, which then transmit the parasite to the definitive mammalian host 
during blood meal intakes [1]. Once inside the dermis, some promastigotes interact with phagocytes 
and are internalised in parasitophorous vacuoles (phagolysosomes), where they differentiate into the 
intracellular amastigote stage and multiply [2, 3]. Amastigotes are released and infect other phagocytes 
when the host cell collapses. Remarkable features of the new harsh environment are acidic pH (4.5-
5.5) and the physiological temperature of the mammalian host (32-37 ºC).  
Phagolysosomal conditions can be mimicked in vitro to grow axenic cultures of the amastigote 
stage. However, there is not agreement about the equivalence of these forms to amastigotes obtained 
from their natural environment. In fact, axenic amastigotes are considered as amastigote-like forms 
(AL) by several authors (e.g. [4, 5]), as they show slightly different features from those of amastigotes 
obtained from host cells. In vitro research supported that concomitant exposure to elevated 
temperatures and acidic pH triggers differentiation of promastigotes to amastigotes [6, 7]. Specifically, 
this could be achieved by combining pH 5.5 and 37 ºC in the presence of 5-7% CO2 [6] or at pH 4.5 
and 37 ºC [8] in a host-free medium. Leishmania promastigotes also cope with temperature increase in 
the absence of pH variation and vice versa [9]. The isolated effects of each factor also induce 
developmentally regulated changes in the shape and gene expression of promastigotes, but neither of 
these environmental conditions alone leads to a complete differentiation of promastigotes to 
amastigotes. Moreover, there is no agreement about the effect of temperature increase. On the one 
hand, it has been reported that this factor stimulates the entry of promastigotes into stationary phase 
[10], whereas Shapira et al. [9] on the other hand, observed a different effect with both light and 
scanning electron microscopy: cell shape was round resembling amastigotes but the flagellum still 
clearly emerged from the cellular body. Regarding the effect of extracellular pH decrease in the 
absence of temperature variation, it has been stated that generation time increases and a specific 
protein of the amastigote stage is expressed under these conditions [11] and that acidification itself 
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leads to the differentiation of promastigotes to metacyclic forms in 48 h; these cells then differentiate 
to amastigotes but only when the temperature is increased [12].  
A descriptive differentiation sequence of promastigotes to amastigotes has been proposed: (1) 
differentiation signal, 0-4 h; (2) disappearance of cell motility, G1 arrest and aggregation, 5-9 h; (3) 
change of shape, 10-24 h; and (4) completion of subsequent differentiation processes, 25-120 h. The 
adaptations necessary for survival in the new harsh conditions inside the host cell are mainly due to 
gene expression modulation. The expression profiles of several genes during this complex 
differentiation process have been studied. For instance, the A2 gene is up-regulated in the first step, as 
well as an amastigote-specific proline transporter in the last step. In contrast, 3’-nucleotidase/nuclease 
(3’NT/Nase) is down-regulated and pentavalent antimonial resistance decreases, presumably due to 
sodium stibogluconate-resistance protein (SbGRP) expression down-regulation in the same step 
(reviewed in [6, 7, 11, 13, 14]). In addition, partial gene expression profiling of L. major, L. mexicana, 
L. infantum and L. donovani amastigotes (axenic and lesion-derived) with respect to promastigotes has 
been reported [15-19]. However, the effects on the transcriptome of particular factors that influence 
differentiation in vivo (mainly temperature increase and pH decrease) have not been studied to date. So 
in this study we have analysed, for the first time, the concomitant (TPS) and the isolated effects of 
temperature and pH shift (respectively, TS and PS) relative to control promastigote culture conditions 
(CC) on the transcriptome of L. infantum by custom genomic DNA microarrays.  
TPS-treated promastigotes differentiate to AL with regard to the up-regulation of the 
amastigote-specific A2 gene and the absence of promastigote-specific glycoprotein 46 (gp46) 
expression as verified by indirect immunofluorescence assay (IFA). In addition, the up-regulation of 
several amastin genes and the down-regulation of 3’NT/Nase and SbGRP genes under TPS and TS is 
in agreement with previous data (reviewed in [13]). None of these genes have been found to be 
differentially regulated under PS. As a consequence, TPS-treated cells are AL and TS-treated ones are 
also progressing towards amastigote differentiation but PS-treated cells do not seem to undergo the 
same differentiation process. After performing IFA, transcriptome analysis was carried out and a large 
set of genes differentially regulated by the effect of both factors was found. A broader analysis of their 
influence on differentiation at the gene expression modulation level by multi-experimental Serial 
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Analysis of Microarrays (SAM) and iterative hierarchical clustering analysis (HCL-ST) of genes with 
respect to their expression modulation has led us to conclude that temperature increase has a greater 
influence than pH decrease on the differentiation process of promastigotes to amastigotes.  
 
RESULTS AND DISCUSSION 
 
Cell growth, gp46-IFA and microarray hybridisation analysis and validation.  
Growth curves of promastigotes cultured under CC (from the mid-logarithmic to the early 
stationary phase), TPS, TS and PS conditions are represented in Figure 1. Proliferation decrease is 
more noticeable under PS conditions than under TPS and TS. Therefore, pH decrease inhibits 
proliferation of parasites at both 37 ºC and 27 ºC, which is in agreement with previous findings [11]. 
Consequently, TPS-treated promastigotes show more pronounced proliferation detention than TS due 
to the effect of acidification (Figure 1). Taken together, these data are consistent with cell proliferation 
arrest during the differentiation process leading up to the amastigote stage, after which mature 
amastigotes are able to multiply.  
Surface glycoprotein gp46 is known to be promastigote-specific. In fact, it is also called 
promastigote surface antigen 2 (PSA2) [20]. This glycoprotein has not been detected in amastigotes, 
although transcripts have been detected at this stage [21]. We have used a monoclonal antibody 
against gp46 in IFA to assess its expression under CC, TPS, TS and PS conditions, and the absence of 
gp46 expression can only be observed in the case of TPS (Figure 2). These findings provide evidence 
for an AL stage after 4 days of TPS exposure. Consequently, TPS-treated cells undergo a more 
intensive differentiation process leading up to AL than TS and PS-treated cells.  
Total RNA was extracted and its integrity and absence of DNA contamination were checked 
by capillary electrophoresis in samples obtained on day 4 (Additional file 1). After mRNA 
amplification, cDNA was synthesised and labelled with Cy3 for CC and with Cy5 for each of the 
conditions assayed. DNA microarray hybridisations with these cDNA samples (TPS vs. CC, TS vs. 
CC and PS vs. CC) were carried out in triplicate. Subsequently, local background was substracted and 
raw data were normalized and t-test performed for three replicates. A total of 225 spots for TPS, 102 
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for TS and 117 for PS vs. CC were selected as they fulfilled the following selection criteria: (i) F ≥ 1.7 
(Cy5/Cy3 ratio if Cy5 > Cy3) or ≤ -1.7 (-Cy3/Cy5 ratio if Cy3 > Cy5), (ii) total relative fluorescence 
intensity value > 5000 FU and (iii) p < 0.05 (Additional file 2). Clones corresponding to selected spots 
had their insert ends sequenced and were mapped against the L. infantum genome to identify 
overlapping genes. Normalized and contrasted microarray hybridisation results of those clones that 
contain known annotated genes are described in Tables 1 and 2 for TPS, 3 and 4 for TS and 5 for PS. 
Hypothetical and unknown genes found to be regulated differentially are described in (Additional file 
3: Table S1, S2, S3, S4, S5 and S6), as well as clones that map against minicircle sequences. Gene 
expression data obtained by microarray hybridisation assays were validated by relative quantitative 
real time PCR (qRT-PCR) in 15% clones (12% genes excluding redundancy expected in a shotgun 
microarray strategy). Molecular function GO annotations are indicated in Tables 1, 2, 3, 4 and 5 in 
order to relate differentially regulated genes with direct acyclic graphs (DAGs) (Additional file 4) and 
molecular function multilevel sector charts (Figure 3). Once the individual effect of each factor on the 
transcriptome was analysed, a multi-experiment comparison (SAM) was performed to determine if 
there were statistically significant differences between PS, TS and TPS expression profiles for each of 
the differentially regulated genes found. Finally, an HCL-ST analysis including control spots allowed 
us to determine the relative distance between the experimental groups: TS is closer than PS to the TPS 
profile (Figure 4).  
 
Concomitant temperature increase and acidification (TPS) leads promastigotes toward AL.  
It has been stated that acidification and the simultaneous effect of temperature increase induce 
the differentiation of promastigotes to amastigotes [6, 7]. In spite of the amastigote-like round cell 
morphology induced under these conditions, we have observed that in a fraction of the population 
flagella are not hidden (Figure 2). Nevertheless, it is important to take into account that we have 
performed the assays in standard medium in which promastigotes are cultured (RPMI supplemented 
with HIFBS) instead of media used for axenic amastigote culture such as Schneider’s medium in order 
to avoid the effect of this factor and focus this study on pH and temperature influence.  
 7
We have observed that TPS-treated cells differentiate into AL after 4 days of stimulation 
(Figure 2), when control promastigotes are reaching the stationary-phase (Figure 1). As mentioned 
before, TPS-treated cells proliferate to a lesser extent than TS-treated ones due to the effect of pH 
decrease. Expression profiling by DNA microarrays has revealed a set of up- and down-regulated 
genes (Tables 1, 2, Additional file 3: Table S1 and S2) that are fully discussed below in the TPS 
expression profile section and illustrated in Figures 3 and 5. Taken as a whole, TPS induces 
promastigote differentiation to AL, as indicated by gp46 IFA and agreement with previous reports on 
the differential expression regulation of the following genes [13]: A2 gene and a set of amastin genes 
(up-regulated); 3’NT/Nase cluster and SbGRP encoding gene (down-regulated).  
 
TS alone leads to a TPS-like expression profile.  
TS-stimulated differentiation processes have been studied only from a morphological point of 
view in L. infantum, but not at the differential gene expression level. For the first time, we have 
described in this research the influence of TS on the whole transcriptome of the parasite (Tables 3, 4, 
Additional file 3: Table S3 and S4). Analogies between TPS and TS expression profiles have been 
observed, namely in the differential regulation of the following genes (Tables 1, 2, 3 and 4, in bold): 
up-regulation of 3’a2rel-related protein, some amastin superfamily genes (see Figure 6 and Amastin 
Superfamily subsection below), ribosome biogenesis regulatory protein (RRS1),  myo-inositol-1-
phosphate synthase (INO1), amino acid transporter aATP11, three conserved hypothetical protein 
genes and eight clones that do not map with any annotated genic sequence; and down-regulation of 
3’NT/Nase, pteridine transporter (PT) LinJ06_V3.1320, glucose transporters (GT), paraflagellar rod 
protein 1D (PFR1D), superoxide dismutase (SOD), phosphatidylinositol-3-kinase (tor2)-like (PI3K), 
peptidyl-prolyl cis-trans isomerase (FKBP) LinJ36_V3.0250, calmodulin, lathosterol oxidase, one 
hypothetical protein of unknown function, six conserved hypothetical proteins and seven clones that 
do not map with any annotated gene. These clones unmapped with genes strongly suggest that gene 
annotations on the L. infantum genomic sequence are incomplete, thus highlighting the advantages of 
using shotgun genomic DNA microarrays and the subsequent genomic library. As pointed out above, 
TPS-induced in vitro stimulation results in a differentiation process that resembles the differentiation 
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of promastigotes to amastigotes inside the phagocytes of the mammalian host. Despite TS itself 
inducing analogous differentiation events and TS-treated cells being called AL [9], the A2 gene is not 
up-regulated (Table 3), all cells show a large flagellum and gp46 IFA is positive under TS (Figure 2).  
Nevertheless, SAM and the subsequent HCL-ST analysis of clones with regard to their fold-change 
values have revealed significant similarities between the transcriptome under TPS and TS (Figure 4). 
Genes of known function with the same expression pattern under TPS and TS are highlighted in bold 
in Tables 1, 2, 3 and 4 (those of unknown function in Additional file 3). The specific regulation of 
these genes by temperature increase is directly correlated to the differentiation to the amastigote stage. 
To sum up, even though TS-treated cells are not differentiated to the same extent as TPS, the 
similarities found between TPS and TS expression profiles when contrasted with the PS profile have 
led us to conclude that temperature has a greater influence than pH on the differentiation process 
leading up to the amastigote stage. 
  
Acidification (PS) contributes little to the differentiation process.  
Some authors have considered that the induction of metacyclogenesis in promastigotes by 
acidic pH is a response common to a variety of Leishmania species [21, 22]. Although there is no 
evidence concerning the metacyclic status of such promastigotes except for morphological 
considerations, proliferation seems to be inhibited by the single effect of acidification (pH 4.5-5.5) 
after 48 h according to [5] and our own observations. Figure 1 shows that promastigote growth is 
limited under these conditions, which is consistent with the generation time increase previously 
observed at pH 4.5 [11]. After an intermediate-term exposure to PS (day 4), two cell morphologies 
were observed: round and promastigote-like, both with emerging flagellum (Figure 2). Moreover, lack 
of A2 gene up-regulation (control gene spotted in each microarray) and an atypical gene expression 
profile have been found. There are some similarities in the expression profiles of TPS-obtained AL 
and PS-treated cells: up-regulation of triacylglycerol (TAG) lipase (TGL), translation factor SUI 
(TFSUI1)–also up-regulated under TS-, ubiquitin conjugating enzyme-like and five clones that do not 
map with any annotated gene; down-regulation of a conserved hypothetical protein and a gene still to 
be annotated; and the previous finding of an amastigote-specific protein induced by pH decrease [11]. 
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In addition, 60S acidic ribosomal protein P2, 60S ribosomal protein L31 [23], ribosomal protein S29 
and RNA binding protein rggm [24] are up-regulated in intracellular amastigotes according to Serial 
Analysis of Gene Expression (SAGE), which is due to PS (Table 5). In spite of this, the vast majority 
of differentially regulated genes under PS (Tables 5, Additional file 3: Table S5 and S6) have not been 
found to match up with those of the TPS and TS profiles. In fact, SAM output of differentially 
modulated genes between PS, TS and TPS was analysed by HCL-ST, which revealed that the most 
distant experimental group is PS (Figure 4).  Moreover, there are opposite gene expression regulation 
events between TPS and PS: down-regulation under TPS and up-regulation under PS of glucose-6-
phosphate N-acetyltransferase gene (GNAT), sphingolipid ∆4-desaturase, prostaglandin F synthetase 
(PGFS), eukaryotic translation initiation factor 5a (eIF5a) and two clones that do not map with any 
annotated sequence. Furthermore, there is also a lack of resemblance with the metacyclic promastigote 
profile [25], except for the up-regulation of 60S acidic ribosomal protein LinJ27_V3.1300 and some 
clones probably containing contig 957 guide RNA (gRNA) sequence (Additional file 3: Table S7 and 
S8). Considered together with the HCL-ST analysis of gene expression, these data suggest that 
intermediate-term exposure of promastigotes to PS leads to forms with features that do not match with 
any of the stages of the parasite’s biological cycle (Figure 4) except for explained coincidences. 
Consequently, although pH has a role in differentiation, temperature is more relevant.   
 
TPS-induced expression profile.  
Overview: Gene Ontology term annotations. All genes identified as potentially regulated 
under these conditions were re-annotated with BLAST2GO to describe globally the influence of TPS 
on the L. infantum transcriptome. Despite the useful overview provided by this analysis, which has 
revealed the functions of some hypothetical proteins, specific genes of trypanosomatid parasites like 
amastins or A2 cannot be correlated to any of the terms included in the database, as they do not show 
any known activity. The analysis of GO molecular function terms associated with a TPS-induced 
profile (Figure 3A and B) indicates an increase in galactosyltransferase (also observed by SAGE [24]), 
nucleoside triphosphatase activity and amine transmembrane transporter activities and a decrease in 
transcripts with associated GO molecular function term annotations such as cyclase, protein kinase and 
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calcium-related cysteine peptidase (all related to signal transduction processes), translation initiation 
and elongation factor and oxidoreductase activities related to electron transport. These findings at the 
molecular function level can be clearly described at the biological process GO term level (Figure 3C 
and D): the down-regulation of several genes related to the regulation of translational initiation, 
elongation and post-translational modification indicates that protein biosynthesis and modification is 
more active in stationary-phase promastigotes rather than in AL. The same occurs with signal 
transduction, prostaglandin F and porphyrin biosynthesis. Genes related to biopolymer and lipid 
metabolic processes, glycosylation of proteins and regulation of cellular processes are up-regulated in 
TPS-induced AL. Nevertheless, there are some common biological process GO terms that are up- and 
down-regulated simultaneously, but this refers to different genes in each case: electron transport 
activity is referred mainly to cytochrome b5 reductase at CC (it is involved in electron transport to the 
sphingolipid-∆4-desaturase reaction), while trypanothione reductase (TR) and the ABC transporter 
subfamily E (ribonuclease L-inhibitor) gene (ABCE) are both related to the same term; the amino acid 
transport term is also present at both stages, but nucleotide sequences of the corresponding aminoacid 
permeases are different, which suggests that a different transporter is used in each stage.   
The resulting microarray data for the TPS-induced AL expression profile analysis is discussed 
in the next subsections according to the iterative HCL-ST (Figure 4) and BLAST2GO-based analyses 
(Figure 3 and Additional file 4). Moreover, it is illustrated schematically in Figure 5 with regard to the 
leishmanial surface, cytoskeleton, secretory pathway, metabolic and signalling processes. Direct 
acyclic graphs (DAGs) (Additional file 4) have been associated with genes shown in Tables 1, 2, 3, 4 
and 5 by means of custom codes assigned in brackets after the name of each gene annotation. 
Amastin superfamily. Several proteins from the uncharacterised surface amastin superfamily 
have been shown to be up-regulated basically in the amastigote stage of Trypanosoma cruzi, L. major 
and L. infantum [26, 27]. The microarray-based transcriptome analysis contained in this study has 
revealed that eleven amastin genes are up-regulated under TPS, ten out of these under TS but none 
under PS. In fact, SAM highlights significant differences in the expression pattern of the eleven 
amastin genes and the subsequent amastin HCL-ST analysis supports the same expression pattern 
except for  LinJ34_V3.2660 (Figure 6A). Furthermore, these amastin genes have been reported to be 
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up-regulated in intracellular and axenic amastigotes by microarrays [28] and SAGE [24]. According to 
TMHMM predictions, these amastins contain 4 transmembrane, 3 inner and 2 outer domains, except 
for LinJ34_V3.1720, which contains a 300 amino acid long N-terminal (N-ter) region followed by an 
additional short transmembrane domain. Outer domains are variable among amastin superfamily 
members, although they are very similar in a given amastin group or class (Figure 6B and C). 
Amastins LinJ08_V3.0680/0690 and LinJ08_V3.0700/0710 were previously found to be up-regulated 
in metacyclic promastigotes [25], which supports that amastin genes are not amastigote markers. The 
expression rate of these genes increases as the life cycle progresses. 
A2-A2rel cluster. A2 gene cluster was first identified in L. donovani, where A2 transcripts are 
abundant in amastigotes but hardly detectable in promastigotes [29]. These molecules were proposed 
as virulence factors that enhance survival of the amastigote inside the macrophage [30]. It has been 
suggested that a balance between A2 and A2rel proteins is required for the parasite’s survival [31].  L. 
donovani and L. infantum A2 genes were spotted onto the microarrays as amastigote-specific control 
genes. We have observed an increase in the corresponding transcript levels under TPS in the 
hybridisation analysis (Table 3). In addition, our results indicate that TPS and TS elicit the up-
regulation of 3’a2rel-related transcripts in L. infantum.  
DNA repair and replication, gene expression and secretory pathway. A member of 
minichromosome maintenance complex protein (mmc) 2/3/5 family (PFAM annotation PF00493) is 
down-regulated and an RNA binding protein (RNAbp) up-regulated in TPS-induced AL. mmc and 
RNAbp are involved in DNA replication according to GO biological process annotation. The histone 
H3 gene is up-regulated under TPS, as well as in intracellular amastigotes according to SAGE [23]. It 
is also involved in nucleosome assembly and DNA repair according to GO annotation. 
With regard to gene expression and protein processing, a hypothetical transcription regulator 
gene (HTreg) and RRS1 are up-regulated under TPS, while nucleolar fibrillarin is down-regulated. 
RRS1 is also up-regulated under TS. TFSUI1 is up-regulated under TPS, TS and PS (see above). The 
elongation factor 1α (EF1α) is down-regulated in both TPS-induced AL and in intracellular L. major 
promastigotes as previously reported [32] and IF5a is also down-regulated by TPS, suggesting a 
different translation regulation mechanism under TPS selective pressure. Peptidyl-prolyl cis-trans 
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isomerases FKBP and cyclophilin (Cph) are also down-regulated in TPS-generated AL and FKBP 
under TS. FKBP and Cph are involved in protein folding inside the endoplasmic reticulum (ER) and 
we had already found the down-regulation of both genes in metacyclic peanut lectin non-agglutinating 
promastigotes [25]. As a consequence, Cph and FKBP gene expression decreases throughout the 
parasite’s life cycle. In addition, a hypothetical protein related to calcium ion and protein binding GO 
molecular functions (αGII-HPB) localises to the dimeric α-glucosidase-II complex according to GO 
cellular component analysis and is down-regulated at the level of transcript under TPS.  GNAT is also 
down-regulated and is involved in protein oligosaccharide biosynthesis inside the ER lumen, possibly 
in the glucosylation/deglucosylation cycle. We have found that a Rab GTPase regulator protein 
(RABreg, see further explanation in the Cytoskeleton remodelling subsection) is up-regulated under 
TPS, probably promoting vesicle transport from Golgi apparatus. In addition, β-1,3-
galactosyltransferase-5/6 carries out galactosylation of proteophosphoglycan and lypophosphoglycan 
if required. These genes have been found to be up-regulated under TPS, as it was also reported for 
metacyclic peanut lectin non-agglutinating promastigotes [25] and intracellular amastigotes according 
to SAGE [24].  
Energetic metabolism. TPS-obtained AL down-regulate transcript levels of two glycolitic 
genes: fructose-1,6-bisphosphate aldolase (ALD) and 2,3-bisphosphoglycerate-independent 
phosphoglycerate mutase (PGMBPI). This agrees with the down-regulation of PGMBPI protein in L. 
donovani [33] and transcripts in L. infantum (unpublished data) mature intracellular amastigotes. The 
ALD gene was also found to be down-regulated at the post-transcriptional level in L. mexicana mature 
amastigotes [17] and at the protein level in immature L. donovani amastigotes. By contrast, ALD 
protein is up-regulated in L. donovani mature intracellular amastigotes [33], which differs from TPS-
induced AL. Down-regulation of both genes is consistent with high energy requirements in the 
promastigote stage. ALD and PGMBPI are independent of catabolite regulation and are located in the 
glycosome and the cytosol respectively. Inhibition of glycolysis by ALD and PGMBPI down-regulation 
is consistent with the down-regulation of two GTs under TPS and TS. Both genes are located in 
tandem in chromosome 36 and custom CLUSTALW2 alignments (Additional file 5) illustrate that 
their sequences are identical except for N-terminal regions (N-ter) of coded peptides. qRT-PCR 
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analysis is consistent with the up-regulation of both GT, as well as the up-regulation of GT lmgt2 in L. 
mexicana [17] and L. major [32] intracellular amastigotes. NAD+ supply for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) reaction is assured by the up-regulation of the glycosomal malate 
dehydrogenase (gMDH) gene at CC with respect to TPS. The mitochondrial precursor of acyl-CoA 
dehydrogenase LinJ07_V3.0150 gene (mACDH) is also down-regulated under TPS, which suggests 
that β-oxidation (β-ox) of fatty acids (FA) is activated under such conditions, as well as glucose 
uptake and glycolysis.  
ABCE is up-regulated under TPS and is involved in electron transport. In fact, the only ABCE 
family member studied to date is a multifunctional protein that includes a metal-binding domain 
(PF04068) adjacent to the 4Fe-4S binding domain (PF00037), as well as two ATP-binding 
sites/ATPase domains typical of ABC proteins (PF00005) but it lacks transporter domains. This kind 
of protein has been found in pluricellular eukaryotes but not in yeast and binds directly to RNase L to 
prevent it from binding 5’-phosphorylated 2’,5’-linked oligo-adenylates [34]. The biological role of 
ABC and the meaning of its up-regulation at the level of transcript in TPS-obtained AL are still 
unknown in Leishmania spp. ABCE localises to the kinetoplast according to GO cellular component 
annotation. 
Lipid metabolism. TGL is post-transcriptionally up-regulated under TPS and is involved in sn-
2 and sn-3 hydrolysis of TAGs. CoA can be incorporated in the released FA and enter β-ox, where 
mACDH and 3-ketoacyl-CoA thiolase (thiolase I) are down-regulated. On the other hand, 
monoglyceride lipase (MGL) is down-regulated under TPS.  Another gene with the same regulation 
pattern is a hypothetical protein with a glycerolphosphodiester phosphodiesterase (GPDE) function 
(GO molecular function analysis), which is related to glycerol derivative metabolism.  An additional 
destination for FA is the sphingolipid biosynthesis pathway, in which  sphingolipid-∆4-desaturase  
oxidises dihydroceramide to ceramide in the presence of O2 and Fe as cofactor (Fe3+ reduced to Fe2+) 
[35]. The sphingolipid-∆4-desaturase gene is down-regulated under TPS and is located in the ER 
membrane (GO cellular component analysis), as well as the cytochrome b5 reductase gene (cyt b5 
reductase), which provides reduction power  for desaturases through cytb5. After ceramide 
biosynthesis, a molecule of phosphoinositol can be added inside the Golgi apparatus resulting in 
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inositol phosphoceramide (IPC) for anchoring inositol derivatives. Saturated acyl groups are also the 
precursors of polyinsaturated fatty acids like arachidonic acid, from which prostaglandins are derived. 
PGFS is down-regulated under TPS, while TR is up-regulated. The reaction prior to PGFS is catalysed 
by prostaglandin peroxide synthase (PES) and requires trypanothione in its reduced state. TR 
regenerates reduced molecules for PES reaction, as well as for many other redox processes. Thus, 
increases in PGFS and TR at different stages is not a contradictory fact, given the wide functional 
spectrum of the latter. PGFS is also up-regulated in procyclic promastigotes with respect to 
metacyclics [25] and has been associated with vector competence of procyclic promastigotes. Taken 
together, these data confirm that PGFS levels diminish throughout differentiation. Finally, 1,2-DAG 
can enter inositolphospholipid metabolism, where PI3K is down-regulated under TPS and TS. As 
PGFS, mACDH, thiolase I, sphingolipid ∆4-desaturase and PI3K are down-regulated, the destination 
of 1,2-DAG and FA excess generated by gene up-regulation of TAG lipase remains unclear.  
  The gene coding for 3-hydroxymethylglutaryl-CoA (HMG-CoA) reductase (HMGCR) is  up-
regulated under TPS. This is the rate-limiting step of sterol and isoprenoid biosynthesis . In view of 
this result, ergosterol biosynthesis may be increased in AL. HMGCR localises to the glycosome in 
Leishmania spp., where leucine (in trypanosomatids [36]) must be carried for priming steroid 
biosynthesis (reviewed in [37]). In spite of HMGCR increase in TPS-induced AL, the lathosterol 
oxidase gene has been found previously to be down-regulated in intracellular amastigotes ([28] and 
unpublished custom data) and the analysis reported in this study has revealed that the down-regulation 
of this gene is due to the specific influence of TPS and TS. Lathosterol oxidase yields 7-
dehydrocholesterol . Leishmania parasites lack the enzyme cholesterol:NADP+ ∆7-oxidoreductase, that 
catalyses the conversion of 7-dehydrocholesterol into cholesterol (KEGG database for L. major [38]). 
Cholesterol functions are performed by ergosterol in these organisms. A question arises about the 
destination of 7-dehydrocholesterol in promastigotes (CC). Vitamin D3 (cholecalciferol) is 
synthesised by exciting 7-dehydrocholesterol with a photon (hν), that according to our gene expression 
results may occur inside the insect vector’s gut, where promastigotes are undergoing a developmental 
process. Obviously, the biological meaning of this fact still remains unclear.  
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Porphyrin biosynthesis. The prosthetic heme group is required for many electron transport 
chain proteins (cytochromes), including cyt b5. Leishmania spp. does not have the ability to perform 
porphyrin biosynthesis de novo, because it lacks δ-aminolevulinate synthase, porphobilinogen 
synthase and deaminase and uroporphyrinogen decarboxylase. These parasites are able to acquire 
protophorphyrinogen IX or heme group directly from the mammalian host. Moreover, 
coproporphyrinogen III, protoporphyrinogen oxidases (C(III)O, PO) and a ferrochelatase-like protein 
are annotated in the genome of the parasite, which highlights its ability to perform heme group 
biosynthesis from the substrate coproporphyrinogen III. Interestingly, C(III)O and PO are located in 
tandem in chromosome 6 and are down-regulated under TPS according to our microarray 
hybridisation results. In fact, CC mimic the environment inside the gut of the phlebotominae sand-fly, 
where the parasites cannot acquire heme or protoporphyrin IX. In spite of this, we have not found 
ferrochelatase gene (located in chromosome 17) to be differentially regulated under the experimental 
conditions assayed. This observation is additional evidence backing the hypothesis of gene 
organization in DGCs depending on the post-transcriptional regulation in Leishmania spp (reviewed in 
[39]).  
Redox homeostasis and oxidative stress. TR catalyses the reduction of reactive oxygen radical 
superoxide anion to hydrogen peroxide and is responsible for maintaining the glutathione orthologue 
trypanothione in its reduced form, essential for redox defence systems in trypanosomatids. For this 
reason, TR would be a useful chemotherapeutic target [40]. TRs are members of the NADPH-
dependent flavoprotein oxidoreductase family and are structurally and mechanistically related to 
gluthathione reductase [41]. The disruption of the TR gene in Leishmania decreases the ability to 
survive oxidative stress inside macrophages [41]. The up-regulation of this gene detected under TPS is 
further evidence for TR demand in the amastigote stage. 
Transport. Two different genes coding for 3’NT/Nase are located in tandem in chromosome 
31 and are down-regulated under TPS and TS, as well as in intracellular amastigotes according to 
unpublished custom data and previous analyses (reviewed in [13]). CLUSTAL alignments show exact 
identity in the central region, and differences between N-ter and C-ter domains. 3’-NT/Nase is 
essential for Leishmania parasites because they are not able to synthesise purines de novo. It localizes 
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to the plasma membrane, may play a role in purine acquisition and its substrates are 3’-ribonucleotides 
(3’AMP and 3’-IMP) and nucleic acids [42-44]. According to previous observations [45], these genes 
are up-regulated in promastigotes in the logarithmic phase of axenic culture and absence of expression 
is shown in the amastigote stage. Interestingly, we have found down-regulation of these genes under 
TPS and TS with respect to CC. Consequently, temperature down-regulates 3’-NT/Nase expression. 
Apart from the GT genes already mentioned, aquaporin (AQ) and Zn transporter (ZnT) genes 
are down-regulated under TPS. The AQ gene is related to changes in cell volume and shape during the 
life cycle of the parasite and it also acts both as an osmotic sensor and in passive transport of solutes. 
It may be related to the osmotactic response shown by the promatigote stage inside the insect vector 
for migration to the foregut [46]. In addition, four different aminoacid permeases are differentially 
regulated: two are up-regulated (LinJ31_V3.0590 and LinJ31_V3.1580) and two down-regulated 
(LinJ27_V3.0530 and LinJ31_V3.0610). Furthermore, three different pteridine transporter genes are 
differentially regulated by the effect of temperature and pH: PT3 LinJ10_V3.0410 and PT 
LinJ14_V3.1440 are up-regulated under TPS, while PT LinJ06_V3.1320 is down-regulated, and this 
pattern is repeated under TS except for PT3. Trypanosomatids are auxotrophes for pteridines and 
therefore they depend on exogenous sources of these compounds. Finally, the vacuolar type proton-
translocating pyrophosphatase gene (vH+-PPi) is down-regulated under TPS. 
Signal transduction and cell cycle regulation. Protein kinase and cAMP signalling pathways 
have not been elucidated in Leishmania to date. A first approach is to find the TPS-generated down-
regulation of a receptor-type adenylate cyclase-like (ACR), a serine/threonine protein phosphatase 
(Ser/Thr PPase) and three non-ligated cysteine peptidase/calpain C2 family (C2cp) genes. C2cp genes 
are also involved in cytoskeleton remodelling (see further explanation in the following section). The 
down-regulation under TPS of a serine/threonine protein kinase (Ser/Thr PK) may be related to the 
down-regulation of calmodulin, which binds calcium divalent cations after its activation by PK 
phosphorylation. Ser/Thr PK is also down-regulated under TS. The exact physiological functions of 
the calcium-calmodulin pathway have not been described in Leishmania either and the 
inositolphospholipid regulator pathway also remains uncharacterised. For this reason, there is no 
known biological meaning for the down-regulation of PI3K and the up-regulation of INO1 under TPS 
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and TS found in the microarray hybridisation analysis. INO1 down-regulation has been observed in L. 
infantum axenic and intracellular amastigotes [28]. Apart from this, a cyclin dependent kinase binding 
protein (Cdkbp) and a serine peptidase E from the S51 family (S51) are also down-regulated and 
might be involved in S-phase or mitosis entry.  
Cytoskeleton and flagellum. Several genes associated with the flagellar and paraflagellar rod 
structures are down-regulated under TPS: coronin, dynein heavy chain LinJ36_V3.2010 and 
LinJ26_V3.1000 and PFR1D, the latter also being up-regulated under TS. Dynein heavy chain 
LinJ26_V3.1000 down-regulation has also been described in AL [28] and intracellular amastigotes 
(unpublished data). Apart from that, we have found that an unknown tubulin-associated GTPase is up-
regulated under TPS, as well as RABreg, an activator of prenylated RAB GTPases. An analogue of a 
RAB small GTPase is up-regulated in L. major amastigotes and may be related with pathogeny, as 
vesicle transport is essential for extracellular nutrient acquisition, release of virulence factors, 
microbicidal resistance and evasion of host immune responses [47]. In addition, calpains are involved 
in cytoskelleton remodelling and signal transduction in kinetoplastid parasites (reviewed in [48]). µ-
calpain C2cp LinJ20_V3.1230 (see also the Signal transduction and cell cycle regulation subsection) 
is down-regulated under TPS and up-regulated in metacyclic promastigotes [25]. Moreover, L. 
mexicana [17] and L. donovani [33] mature intracellular amastigotes also down-regulate this gene. As 
a consequence, the greatest transcript levels of µ-calpain are reached in metacyclic promastigotes. 
 gRNAs.According to BLAST outcome mapping against GenBank database, 19 clones map 
against 4 different minicircle sequences (contig 200, 692, 878 and 957) (Additional file 3: Table S7) 
and according to the microarray hybridisation analysis, they must contain an up-regulated gene under 
TPS. Provided that each minicircle contains only a single gRNA gene for site-specific uridine 
insertion/deletion type RNA editing, 4 gRNA genes with unknown target are presumably up-regulated 
under TPS. The gRNA genes corresponding to contigs 878 (1 clone) and 957 (16 clones) have also 
been found to be up-regulated under PS (Additional file 3: Table S8) and were previously found as up-
regulated in metacyclic promastigotes [25].  
Other genes. Leishmania promastigotes use chitinase to break the chitinous peritrophic 
membrane inside the gut of the sand-fly vector [49]. Chitinase gene is up-regulated in TPS-induced 
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AL, which is consistent with chitinase overexpression reported in amastigotes, as well as the 
associated enhanced lesion development observed in mice [50], suggesting an additional or different 
function for this gene. The microarray hybridisation analysis has also revealed that SbGRP is down-
regulated in TPS-induced AL forms, as well as in L. mexicana [17], L. major [32] and L. infantum 
(unpublished data) intracellular amastigotes. In fact, a decrease in pentavalent antimonial resistance is 
a feature of AL, together with round morphology typical of amastigotes, the up-regulation of A2 
cluster and the down-regulation of 3’NT/Nase, as reviewed previously [13].  
The membrane bound acid phosphatase gene (MBAP) is down-regulated under TPS as 
revealed by microarray analysis. There is evidence to confirm that it is essential for cell survival, 
because it plays a critical role in nutrition. It is located in small vesicles between the Golgi apparatus 
and the flagellar pocket (secretory pathway) [51]. MBAP levels have been described as being higher in 
procyclic promastigotes rather than in metacyclics. It was reported that its activity is higher in virulent 
clones and consequently, it was supposed that it was involved in virulence in spite of the higher levels 
of MBAP protein found in logarithmic phase promastigotes according to [52], but further experiments 
have demonstrated the opposite. L. mexicana MBAP knockout parasites show that it is neither 
involved in the infection process nor required for amastigote survival in the infected host cell [51]. 
This supports our results concerning MBAP gene down-regulation in TPS-induced AL forms. 
Hybridisation analysis has revealed the down-regulation of a hypothetical protein (CoB) with 
copper ion binding/transport and chaperone GO molecular functions under TPS. CoB is located in the 
mitochondrial lumen according to GO cellular component term analysis. Two genes from the 
HASP/SHERP cluster are differentially regulated by TPS: a small hydrophilic ER-associated protein 
(SHERP) is down-regulated by TPS; and hydrophilic surface protein (HASPB) is up-regulated under 
TPS, as well as in intracellular L. donovani promastigotes at the post-translational level [33]. In 
contrast, down-regulation was reported in L. major [16]. Despite these genes being previously 
presumed to be metacyclic promastigote-specific in L. major [16], we have reported a different pattern 
for HASPB in L. infantum. Finally, this analysis also revealed the up-regulation of an esterase-like 
protein, carbamoyl-phosphate synthetase (CPS), a short chain dehydrogenase and ubiquitin-
conjugating enzyme-like proteins in TPS-induced AL, and the latter also under TS. 
 19
  
CONCLUSIONS 
 
Absence of gp46 expression observed by means of IFA and up-regulation of the amastigote-
specific A2 gene has been found in TPS-treated cells. As a consequence, we know that TPS leads to 
differentiation into AL. The up-regulation of several amastin genes and the down-regulation of 
3’NT/Nase and SbGRP genes under TPS and TS point to a developmental process towards amastigote 
differentiation by the combined effect of temperature increase and acidification and the single effect of 
temperature. By contrast, none of these genes have been found to be differentially regulated under PS, 
which suggests that pH decrease itself does not prompt amastigote differentiation in the parasite. A 
wider analysis of TPS-, TS- and PS-induced expression profiles throughout HCL-ST clustering 
analysis of gene expression supports temperature shift alone or combined with acidification as 
triggering differentiation towards the amastigote stage whereas acidification itself does not. In fact, we 
have described examples of known annotated genes taken directly from the microarray output, namely 
the up-regulation of RRS1, INO1 and aATP11 and the down-regulation of 3’NT/Nase, PT, GT, SOD, 
PI3K, FKBP, calmodulin and lathosterol oxidase. These observations have led us to conclude that 
temperature increase is more relevant than pH decrease in the differentiation process to the amastigote 
stage with regard to transcriptome variation in L. infantum.  In addition, we have provided the first 
description of transcriptome variation induced by the specific influence of temperature increase and 
acidification.  
 
METHODS 
 
Parasite cultures and RNA isolation. 
Cultures of L. infantum isolate M/CAN/ES/98/10445 (zymodeme MON-1) from early 
passages after axenization were grown at a starting density of 4 x 106 mid-logarithmic phase 
promastigotes/ml in RPMI 1640 medium supplemented with L-glutamine (Cambrex, Karlskoga, 
Sweden), 10% heat inactivated foetal bovine serum (HIFBS) (Cambrex) and 100 µg/ml streptomycin – 
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100 IU/ml penicillin (Cambrex) at 27 ºC/pH7.2 (CC), 37 ºC/pH4.5 (TPS), 37 ºC/pH7.2 (TS) or 27 
ºC/pH4.5 (PS). Cell density was counted daily and promastigotes were harvested at 2000g for 10 min 
on day 4. RNA isolations were performed from 2 x 108 cells/ml of TRIzol® reagent (Invitrogen, La 
Jolla, CA) following the manufacturer’s instructions. Three biological replicates of the cultures were 
carried out for each of the conditions described. 
 
gp46 IFA. 
 Cells were fixed with acetone:methanol (1:1) at -20 ºC for 10 min at a density of 2 x 106/5 µl 
drop. Then, they were incubated with purified anti-gp46 monoclonal IgG antibody at 37 ºC for 30 min 
in a hydration chamber, washed three times with PBS by mild agitation for 10 min, incubated with 
fluorescein isotiocyanate (FITC)-conjugated goat anti-mouse IgG antibody (Serotec, Raleigh, NC) and 
0.1% Evans’ Blue (Fisher, Pittsburgh, PA). Washes were repeated and preparations mounted with 
90% glycerol. Negative control of the primary antibody was anti-rabbit complement factor H 
monoclonal IgG and the first incubation was carried out with PBS for the negative control of the 
secondary antibody. SIM 110 monoclonal IgG antibody against soluble leishmanial antigens (SLA) 
was used as a positive control. Anti-gp46, anti-rabbit factor H and SIM110 antibodies were kindly 
provided by Mercedes Domínguez (Centro Nacional de Microbiología, Virología e Inmunología 
Sanitarias, Instituto de Salud Carlos III, Majadahonda, Spain).  
 
L. infantum DNA microarray construction and hybridisation.  
L. infantum DNA microarray construction and hybridisation assays were carried out as 
described previously [25]. To summarize, microarrays were generated by long template PCR 
amplification from  a complete shotgun DNA-pUC18 genomic library with m13-pUC18 primers and 
spotting onto epoxy-coated slides. RNA quality was assessed by capillary electrophoresis, mRNA was 
amplified, cDNA was synthesised and indirectly labelled and L. infantum DNA microarrays blocked, 
hybridised and washed as detailed in [25]. Hybridisation assays were performed as follows: 37 
ºC/pH4.5 vs. 27 ºC/pH7.2 (TPS vs. CC), 37 ºC/pH7.2 vs. 27 ºC/pH7.2 (TS vs. CC) and 27 ºC/pH4.5 
vs. 27 ºC/pH7.2 (PS vs. CC). Hybridised microarrays were scanned and fluorescence intensity was 
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analysed for Cy3 (532 nm) and Cy5 (635 nm) with local feature background subtraction (GenePix 
4100A scanner and software, Axon Instruments, Foster City, CA). LOWESS per pin algorithm was 
used to normalise raw data (AlmaZen software, BioAlma, Tres Cantos, Spain). After that, comparative 
analysis of the replicates by paired t-test and selection of spots with meaningful values of stage-
specific regulation were performed as described [25].  
 
DNA sequencing and analysis.  
Clones corresponding to selected spots were sequenced and mapped following a strategy that 
has already been described in detail [25]. Briefly, insert ends were dideoxi-sequenced with m13-
pUC18 primers and aligned against the L. infantum genome project sequence in General Feature 
Format (GFF) deposited in a GBrowse database. Forward and reverse reads were mapped to define the 
boundaries of the clones in the genome of L. infantum. Depending upon the insert length, the success 
of sequencing reactions of both ends and genome sequence complexity, three possibilities arose: when 
one pair of convergently oriented alignments separated by up to 11 Kbp were found, the clone 
mapping outcome was defined as type a; when more than one pair of alignments fulfilled those 
conditions, the best pair of alignments was used to define the boundaries of the clone, resulting in a 
type b outcome; and when those requirements were not fulfilled (incongruent pair of alignments or 
unpaired alignments), the outcome was defined as type c. Some of the clones were annotated by a 
custom Glimmer 3.0 analysis because they did not map against genes previously annotated on the L. 
infantum genome project sequence. Stage-specifically regulated genes were re-annotated and analysed 
with BLAST2GO to establish molecular function and biological process GO term distribution among 
them based on α-scores [53]. 
 Multi-experiment SAM and the subsequent iterative hierarchical clustering-support tree 
analysis (HCL-ST) were carried out with TIGR’s MultiExperiment Viewer 4.3 (MEV) by introducing 
normalised microarray hybridisation data matrixes (including medians and standard deviations of 
intensity and F values) of clones with significant differential regulation in each individual experiment. 
SAM p-value cutoff was 0.05, the same as for the previous independent t-tests for each experiment. 
HCL-ST was performed independently for significant and non-significant genes. ST algorithm with a 
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jackknifing resampling option and 100 iterations for the construction and clustering of the gene 
expression matrix were applied in HCL-ST analysis. CLUSTALW2 was used for sequence alignments 
of amastin, GT and 3´NT/Nase genes differentially regulated by the effect of pH and/or temperature 
and CBS’s TMHMM 2.0 for the prediction of transmembrane helices in these proteins. 
   
qRT-PCR.  
qRT-PCR reactions were performed to determine whether a gene overlapping with a type c 
sequence end is developmentally regulated or to ascertain which gene is developmentally regulated in 
the clones overlapping more than one gene. We described previously the procedure applied [25]. The 
reference gene was 18S rRNA. When there were two copies of a gene in tandem in a given clone but 
one of the copies lacked a segment of the 5’ end or differed in a specific sequence (GT and 3’NT/Nase 
genes), two pairs of primers were designed for qRT-PCR. A complete list of primers used for qRT-
PCR is provided in Additional file 5. 
 
ABBREVIATIONS  
 
aap, amino acid permease; aATP11, amino acid transporter 11; ABCE, ABC transporter subfamily E 
(ribonuclease L-inhibitor) gene; ACR, receptor-type adenylate cyclase; ACT, acyl-CoA transferase; 
AL, amastigote-like; ALD, fructose-1,6-bisphosphate aldolase; AQ, aquaporin; CC, culture control 
conditions; C2cp, cysteine protease family C2; cdkbp, cyclin-dependent kinase binding protein; 
C(III)O, coproporphyrinogen oxidase; CoA, coenzyme A; CoB, cofactor binding protein; Cph, 
cyclophilin; CPS, carbamoyl phosphate synthetase; Cy, cyanin; cyt b5, cytochrome b5; DAG, direct 
acyclic graph; 1,2-DAG, 1,2-diacylglycerol; DGC, directional gene cluster; DHAP, dihydroxyacetone 
phosphate; EF1α, elongation factor 1 α; eIF5a, eukaryotic translation initiation factor 5a; ER, 
endoplasmic reticulum; ETCH, electron transport chain; F, Fold change; FA, fatty acid; FITC, 
fluorescein isotiocyanate; FKBP, FK506-binding protein; FU, Fluorescence Units; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; αGII-HPB, hypothetical calcium ion binding protein 
from α-glycosidase II complex; gMDH, glycosomal malate dehydrogenase; GNAT, glucose-6-
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phosphate N-acetyltransferase; GO, Gene Ontology; gp46, 46 KDa surface glycoprotein; GPDE, 
glycerolphosphodiester phosphodiesterase; gRNA, guide RNA; GT, glucose transporter; H3, histone 
H3; HASPB, hydrophilic surface protein B; HCL-ST, Hierarchical clustering-Support Tree; HIFBS, 
heat inactivated foetal bovine serum; HMG-CoA, 3-hydroxymethylglutaryl-CoA; HMGCR, HMG-
CoA reductase; HPT, hypothetical protein transport protein; HTreg, hypothetical transcription 
regulator; IFA, immunofluorescence analysis; IPC, inositol phosphoceramide; INO1, myo-inositol-1-
phosphate synthase; LOWESS, Locally Weighted Scatter Plot Smoothing algorithm; LPG, 
lypophosphoglycan; mACDH, mitochondrial acyl-CoA dehydrogenase; MBAP, membrane bound acid 
phosphatase; MEV, Multi Experiment Viewer; MGL, monoglyceride lipase; mmc, minichromosome 
maintenance complex protein; MRP, multidrug resistance protein; NPC, nuclear pore complex; 
3’NT/Nase, 3’-nucleotidase/nuclease; β-ox, β-oxidation of FA; PES, prostaglandin peroxide synthase 
complex; PFR1D, paraflagellar rod protein 1D; PG, phosphoglycerate; PGFS, prostaglandin F 
synthase; PGMBPI, bisphosphoglycerate-independent phosphoglycerate mutase; PI3K, 
phosphatidylinositol triphosphate kinase; PO, protoporphyrinogen oxidase; PPG, 
proteophosphoglycan; PS, pH shift; PSA2, promastigote-specific surface antigen 2; PT, pteridine 
transporter; qRT-PCR, relative quantitative real time PCR; R, set of ribosomal proteins; RABreg, Rab 
GTPase regulator; RNAbp, RNA-binding protein; RRS1, ribosome assembly protein; S51, serine 
peptidase A family S51; SAGE, Serial Analysis of Gene Expression; SAM, Serial Analysis of 
Microarrays; Ser/Thr PK, serine/threonine protein kinase; SbGRP, sodium stibogluconate resistance 
protein; Ser/Thr PPase, Ser/Thr protein phosphatase; SHERP, small hydrophilic ER-associated 
protein; SLA, soluble leishmanial antigen; SOD, superoxide dismutase; TAG, triacylglycerol; TCA, 
tricarboxylic acid cycle; TFSUI1, translation factor SUI1; TGL, TAG lipase; TPS, temperature-pH 
shift; TS, temperature shift; TR, trypanothione reductase; vH+-PPi, vacuolar-type proton-translocating 
pyrophosphatase; ZnT, Zn transporter. 
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FIGURE LEGENDS 
 
Figure 1. Average growth curves of control and temperature/pH-treated L. infantum 
promastigotes. Three replicates of the cultures were performed for each of the conditions assayed. 
RNA samples were extracted and processed for transcriptome analysis on day 4. Growth arrest is 
induced by pH decrease. 
 
Figure 2. gp46 IFA. Samples of all the experimental conditions described in this article were 
collected on day 4 for IFA analysis. (A-D) CC; (E-H) TPS; (I-L) TS; and (M-P) PS. Incubations were 
performed with: PBS as negative control for the FITC-conjugated anti-mouse IgG secondary antibody 
(A, E, I, M); monoclonal anti-rabbit complement factor H primary antibody negative control (B, F, J, 
N); SIM110 monoclonal anti-SLA as positive control (C, G, K, O); and monoclonal anti-gp46 (D, H, 
L, P). As a summary, gp46 is expressed under CC, TS and PS but not in TPS-treated AL.  
 
Figure 3. Multilevel sector charts of α-scores for GO molecular functions annotated on 
differentially regulated genes under TPS. (A) Molecular function GO terms annotated on down-
regulated genes under TPS. (B) Molecular function GO terms annotated on up-regulated genes under 
TPS. (C) Biological process GO terms annotated on down-regulated genes under TPS. (D). Biological 
process GO terms annotated on up-regulated genes under TPS.  
 
Figure 4. HCL-ST of genes differentially modulated under TPS, TS and /or PS. After performing 
SAM for all experimental groups, HCL-ST analysis was performed independently for (A) genes with 
(B) and without significant differences between groups according to SAM. Support Tree algorithm 
with a jackknifing resampling option and 100 iterations for the construction and clustering of gene 
expression matrix were applied in HCL-ST. Clones in (A) were grouped into 26 clusters and clones in 
(B) in two clusters depending on differential regulation. This analysis confirms that expression profile 
similarity is higher between TPS and TS than between TPS or TS and PS. Control spots LiA2, LdoA2, 
Lip36, Lipolb, Lihsp70, Ldohsp70 and Lmahsp70 show significant differences in gene expression 
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between the experimental groups (A2 gene is up-regulated under TPS and hsp70 under PS) and 
LiTopoII, LiDNAg, Lamhsp70, LiGAPDH, LdoGAPDH and herring DNA do not. Clones with 
significant differences between the experimental conditions are identified in Additional file 6. 
 
Figure 5. Scheme representing differentially regulated genes under TPS and their subcellular 
localisation and/or functional relations. Up-regulated genes are represented in red colour (Cy5) and 
down-regulated in green (Cy3). Further explanations in the TPS expression profile subsection, which 
is included in the Results and Discussion section. 
 
 Figure 6. Amino acid sequence and domain analysis of amastin genes found to be differentially 
regulated under TPS and TS. (A) MEV comparison of differential regulation under TPS, TS and PS. 
(B) Sequence similarity tree representing distances between amastin genes found to be up-regulated 
under TPS and TS. (C) Amino acid sequences were aligned with CLUSTALW2 software. The darker 
the position is highlighted the more conserved the residue is. The boundaries of inner, transmembrane 
and outer domain sequences predicted with TMHMM 2.0 software are represented below sequence 
alignments. 
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TABLES. 
Table 1. Up-regulated genes after 37 ºC/pH4.5 treatment (day 4) in L. infantum.  
Clone F Log2F ±   p GenBank e-value Id. Annotated Gene Function (GO terms in Figure 
S3., additional  
qRT-PCR 
  SD  GSS Fw Rv 
Def. 
 file 4) +/- F ± SD 
Lin11D
7 
4.78 2.3 ± 0.2 0.00
2 
GS59885
4 
6e-
118 
0 b LinJ31_V3.0
460 
Amastin, putative (uTPS0) + 7.8 ± 
0.2 
LinJ08_V3.0
680 
Amastin-like protein (uTPS0) N.D.  Lin19D
1 
1.88 0.9 ± 0.3 0.02
8 
GS59885
5 
 
3e-
18 
0 b 
LinJ08_V3.0
690 
Amastin-like protein (uTPS0) N.D.  
Lin22E1
2 
2.79 1.5 ± 0.1 0.00
1 
GS59885
6 
0 0 b LinJ31_V3.1
850 
Amino acid permease (uTPS13) N.D.  
Lin33G
2 
4.01 2.0 ± 0.8 0.04
4 
GS59885
7 
6e-
118 
6e-
118 
b LinJ34_V3.4
370 
Amastin-like surface protein, putative 
(uTPS0) 
N.D.  
Lin34G
1 
1.81 0.9 ± 0.1 0.00
8 
GS59885
8 
0 0 a LinJ16_V3.0
790 
Chitinase (uTPS18, uTPS8) N.D.  
Lin36B
8 
1.99 1.0 ± 0.2 0.01
5 
GS59885
9 
0 0 b LinJ30_V3.3
230 
3-hydroxy-3-methyglutaryl-CoA reductase, 
putative (uTPS21, uTPS12) 
N.D.  
Lin50G
2 
3.38 1.8 ± 0.1 0.00
0 
GS59886
0 
0 4e-
153 
b LinJ34_V3.2
660 
Amastin-like surface protein (uTPS0) + 1.8 ± 
0.0 
LinJ24_V3.1
230 
Hypothetical protein, conserved  N.D.  Lin54G
3 
1.84 0.9 ± 0.3 0.02
7 
GS59886
1 
0 0 b 
LinJ24_V3.1
240 
Translation factor SUI1, putative (uTPS0) + 3.1 ± 
0.1 
LinJ05_V3.0
340 
Hypothetical protein, conserved N.D.  Lin62D
3 
1.92 0.9 ± 0.4 0.04
0 
GS59886
2 
0 0 b 
LinJ05_V3.0
350 
Trypanothione reductase (uTPS10, uTPS14, 
uTPS20) 
+ 3.8 ± 
0.4 
Lin62D
10 
1.76 0.8 ± 0.3 0.05
1 
GS59886
3 
0 0 b LinJ17_V3.1
150 
Esterase-like protein (uTPS5) + 18.5 ± 
1.5 
LinJ22_V3.0
470 
Hypothetical protein, conserved N.D.  Lin66A
8 
3.59 1.8 ± 0.4 0.01
3 
GS59886
4 
0 0 b 
LinJ22_V3.0
480 
Ubiquitin-conjugating enzyme-like protein 
(uTPS0) 
+ 2.3 ± 
0.2 
LinJ33_V3.2
470 
Succinyl-CoA:3-ketoacid-CoA transferase, 
mitochondrial precursor, putative (3-oxoacid-
CoA transferase)  
- 
-1.3 ± 
0.3  
Lin66F8 1.92 0.9 ± 0.2 0.01
7 
GS59886
5 
0 3e-
132 
a 
LinJ33_V3.2
480 
Hypothetical protein, conserved/RABreg 
(uTPS17) 
N.D.  
Lin77H
8 
5.63 2.5 ± 0.5 0.01
6 
GS59886
6 
0 0 b LinJ08_V3.0
690 
Amastin-like protein (uTPS0) N.D.  
Lin86H
7 
3.06 1.6 ± 0.2 0.00
4 
GS59886
7 
0 2e-
101 
b LinJ08_V3.0
700 
Amastin-like protein (uTPS0) + 9.5 ± 
0.3 
Lin87H
2 
4.20 2.1 ± 0.3 0.00
8 
GS59886
8 
3e-
15 
3e-
33 
b LinJ08_V3.0
690 
Amastin-like protein (uTPS0) N.D.  
Lin89D
9 
1.71 0.8 ± 0.3 0.04
3 
GS59886
9 
0 0 b LinJ21_V3.0
770 
ATP-binding cassette sub-family E, 
putative (uTPS9, uTPS11, uTPS24, 
uTPS28) 
N.D.  
LinJ30_V3.0
640 
Ribosome biogenesis regulatory protein 
(RRS1), putative (uTPS0) 
+ 16.4 ± 
0.2 
LinJ30_V3.0
650 
Histidyl-tRNA synthetase, putative  N.D.  
Lin90B
6 
1.71 0.8 ± 0.3 0.04
0 
GS59887
0 
0 0 b 
LinJ30_V3.0
660 
Hypothetical protein, conserved N.D.  
Lin90H
2 
1.76 0.8 ± 0.1 0.00
5 
GS59887
1 
0 0 b LinJ30_V3.2
200 
RNA-binding protein (uTPS3, uTPS6, 
uTPS15, uTPS16) 
N.D.  
Lin91B
12 
5.24 2.4 ± 0.3 0.00
4 
GS59887
2 
0 0 b LinJ34_V3.2
660 
Amastin-like surface protein (uTPS0) + 1.8 ± 
0.0 
LinJ28_V3.2
060 
Zinc transporter, putative (uTPS23) + 45.7 ± 
0.5 
Lin92H
5 
2.48 1.3 ± 0.5 0.04
1 
GS59887
3 
0 0 b 
LinJ28_V3.2
070 
Hypothetical protein, conserved N.D.  
Lin93E3 1.83 0.9 ± 0.4 0.03
3 
 0 0 b LinJ10_V3.0
410 
Pteridine transporter ft3, putative (uTPS0) N.D.  
Lin104
C10 
6.68 2.7 ± 0.1 0.00
1 
GS59887
4 
0 0 b LinJ08_V3.1
320 
Amastin-like protein (uTPS0) N.D.  
LinJ06_V3.1
200 
Hypothetical protein, conserved N.D.  Lin106
A1 
2.43 1.3 ± 0.0 0.00
0 
GS59887
5 
0 0 c 
LinJ31_V3.0
590 
Amino acid transporter aATP11, putative 
(uTPS13) 
+ 2.6 ± 
0.0 
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LinJ14_V3.1
440 
Pteridine transporter (uTPS0) + 1.9 ± 
0.0 
Lin113
C3 
1.87 0.9 ± 0.1 0.04
0 
GS59887
6 
3e-
74 
0 a 
LinJ14_V3.1
450 
Myo-inositol-1-phosphate synthase 
(uTPS0) 
+ 2.1 ± 
0.3 
LinJ30_V3.0
630 
Nitrate reductase, putative (uTPS0) + 3.7 ± 
0.3 
Lin118
A11 
2.90 1.5 ± 0.3 0.01
0 
GS59887
7 
0 7e-
28 
c 
LinJ36_V3.2
480 
Glyceraldehyde-3-phosphate dehydrogenase, 
putative 
N.D.  
Lin119F
3 
3.40 1.8 ± 0.2 0.00
5 
GS59887
8 
0 0 b LinJ25_V3.2
570 
Phosphoglycan beta-1,3-
galactosyltransferase 6 (uTPS22) 
N.D.  
Lin123
D6 
2.91 1.5 ± 0.1 0.00
2 
GS59887
9 
- 0 c LinJ34_V3.2
660 
Amastin-like surface protein (uTPS0) + 1.8 ± 
0.0 
LinJ24_V3.1
230 
Hypothetical protein, conserved N.D.  Lin137
A10 
1.98 1.0 ± 0.3 0.03
9 
GS59888
0 
0 0 b 
 
LinJ24_V3.1
240 
Translation factor SUI1, putative (uTPS0) + 3.1 ± 
0.1 
Lin142
H9 
1.74 0.8 ± 0.1 0.00
4 
GS59888
1 
0 0 b LinJ31_V3.0
460 
Amastin, putative (uTPS0) + 7.8 ± 
0.2 
Lin146E
3 
2.35 1.2 ± 0.4 0.03
8 
GS59888
2 
0 0 b LinJ31_V3.0
590 
Amino acid transporter aATP11, putative 
(uTPS13) 
+ 2.6 ± 
0.0 
Lin156
B2 
1.82 0.9 ± 0.2 0.02
5 
GS59888
3 
0 0 b LinJ33_V3.2
960 
Hypothetical protein, 
conserved/Transcription regulator (uTPS 1, 
uTPS4, uTPS7) 
N.D.  
LinJ22_V3.0
470 
Hypothetical protein, conserved N.D.  Lin162
A9 
4.29 2.1 ± 0.2 0.00
4 
GS59888
4 
0 0 b 
LinJ22_V3.0
480 
Ubiquitin-conjugating enzyme-like protein 
(uTPS0) 
+ 2.3 ± 
0.2 
Lin165E
2 
3.48 1.8 ± 0.2 0.00
4 
GS59888
5 
0 0 b LinJ22_V3.0
680 
3’a2rel-related protein (uTPS0) + 4.0 ± 
0.4 
Lin183
A3 
1.75 0.8 ± 0.1 0.01
0 
GS59888
6 
0 0 b LinJ24_V3.2
250 
Hypothetical protein, conserved/GPDE 
(uTPS26) 
N.D.  
Lin185
A12 
4.53 2.2 ± 0.2 0.00
2 
GS59888
7 
0 0 b LinJ34_V3.2
660 
Amastin-like surface protein, putative 
(uTPS0) 
+ 1.8 ± 
0.0 
Lin188
H2 
3.20 1.7 ± 0.6 0.04
2 
GS59888
8 
0 0 c LinJ08_V3.0
680 
Amastin-like protein (uTPS0) N.D.  
Lin194E
2 
3.22 1.7 ± 0.4 0.02
3 
GS59888
9 
7e-
56 
4e-
153 
b LinJ08_V3.0
710 
Amastin-like protein (uTPS0) + 9.5 ± 
0.3 
Lin197
A12 
1.95 1.0 ± 0.2 0.01
6 
GS59889
0 
0 0 a LinJ31_V3.2
540 
Lipase, putative (uTPS19) N.D.  
Lin201F
8 
2.00 1.0 ± 0.4 0.04
1 
GS59889
1 
0 0 b LinJ31_V3.3
330 
Phosphoglycan beta-1,3-
galactosyltransferase 5 (uTPS22) 
N.D.  
Lin206
B6 
5.40 2.4 ± 0.5 0.01
2 
GS59889
2 
7e-
133 
0 b LinJ22_V3.0
680 
3’a2rel-related protein (uTPS0) + 4.0 ± 
0.4 
Lin210
C4 
2.77 1.5 ± 0.1 0.00
3 
GS59889
3 
0 0 b LinJ08_V3.0
690 
Amastin-like protein (uTPS0) N.D.  
Lin223F
2 
1.73 0.8 ± 0.3 0.04
4 
GS59889
4 
0 0 b LinJ13_V3.0
330 
Unknown/Tubulin associated GTPase 
(uTPS2, uTPS25, uTPS27) 
N.D.  
Lin224
G2 
2.20 1.1 ± 0.2 0.02
3 
GS59889
5 
0 0 b LinJ08_V3.0
720 
Amastin-like protein (uTPS0)0 N.D.  
Lin235
G8 
3.16 1.7 ± 0.2 0.00
3 
GS59889
6 
0 0 b LinJ08_V3.1
320 
Amastin-like protein (uTPS0) N.D.  
Lin245E
2 
2.61 1.4 ± 0.4 0.04
0 
GS59889
7 
0 0 b LinJ22_V3.0
680 
3’a2rel-related protein (uTPS0) + 4.0 ± 
0.4 
LinJ16_V3.0
590 
Carbamoyl-phosphate synthetase, putative 
(uTPS0) 
+ 2.9 ± 
0.4 
Lin267
D9 
2.06 1.0 ± 0.2 0.01
0 
GS59889
8 
9e-
111 
0 b 
LinJ16_V3.0
600 
Histone H3, putative  - 1.3 ± 
0.2 
LinJ08_V3.0
680 
Amastin-like protein (uTPS0) N.D.  Lin274
G6 
5.77 2.5 ± 0.2 0.00
3 
GS59889
9 
0 0 b 
LinJ08_V3.0
690 
Amastin-like protein (uTPS0) N.D.  
Lin275
A8 
2.72 1.4 ± 0.2 0.00
6 
GS59890
0 
0 4e-
168 
b LinJ08_V3.0
720 
Amastin-like protein (uTPS0) N.D.  
Lin276
B6 
1.76  0.8 ± 0.3 0.04
1 
GS59890
1 
0 0 b LinJ31_V3.2
540 
Lipase, putative (uTPS19) N.D.  
Lin294
A11 
4.86 2.3 ± 0.1 0.00
1 
GS59890
2 
0 0 b LinJ08_V3.1
320 
Amastin-like protein (uTPS0) N.D.  
Lin295
D9 
4.40 2.1 ± 0.1 0.00
0 
GS59890
3 
0 0 b LinJ34_V3.1
720 
Amastin-like surface protein, putative 
(uTPS0) 
N.D.  
Lin310F
2 
2.34 1.2 ± 0.5 0.04
6 
GS59890
4 
0 0 b LinJ23_V3.1
220 
Hydrophilic surface protein (HASPB) 
(uTPS0) 
N.D.  
cLinA2 6.45 2.7 ± 0.1 0.00
0 
S69693 - - - - L. infantum A2 gene – DNA microarray 
control spot 
  
cLdoA2 2.51 1.3 ± 0.3 0.02
1 
- - - - - L. donovani A2 gene – DNA microarray 
control spot 
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This table contains clones that map against up-regulated genes (not hypothetical or unknown) with the 
combined effect of temperature increase and pH decrease (TPS). The features described are: clone 
number; F; base-two logarithmic scale F and SD values; p; GenBank GSS accession numbers; e-
values; Def. according to mapping outcomes a, b or c (see brief explanation in the text); Id.; annotated 
gene function (codes for Additional file 4: Figure S3,);  qRT-PCR. When a given clone overlaps with 
more than one annotation, stage-specific regulation is only demonstrated if the qRT-PCR result is 
positive (+). Genes in bold are also up-regulated under TS. 
 
Table 2. Down-regulated genes after 37 ºC/pH4.5 treatment (day 4) in L. infantum.  
e-value qRT-PCR Clone F Log2F ±  
SD 
p GenBank 
GSS Fw Rv 
Def. Id. Annotated Gene Function (GO terms in Figure S4., 
additional file 4) +/- F ± SD 
Lin1G8 -
1.8
0 
-0.8 ± 
0.1 
0.00
9 
GS5989
05 
5e-35 8e-
31 
b LinJ22_V3.1340Serine/threonine protein phosphatase, putative 
(dTPS6) 
N.D.  
Lin4F4 -
2.2
7 
-1.2 ± 
0.3 
0.01
6 
GS5989
06 
0 0 a LinJ31_V3.0430Cysteine peptidase, Clan CA, family C2, putative 
(dTPS0) 
+ 
-3.3 ± 0.1 
Lin9B9 -
1.7
1 
-0.8 ± 
0.2 
0.01
5 
GS5989
07 
5e-26 0 a LinJ36_V3.1010Dynein heavy chain, putative (dTPS0) N.D.  
Lin15D6 -
2.0
5 
-1.0 ± 
0.2  
0.04
2 
GS5989
08 
0 0 a LinJ31_V3.0610Amino acid transporter aATP11, putative (dTPS0) N.D.  
Lin22B1
* 
-
2.0
3 
-1.0 ± 
0.2 
0.01
6 
GS5989
09 
0 0 a LinJ23_V3.1400Coronin, putative (dTPS0) + 
-4.9 ± 0.7 
Lin21H1
0 
-
1.9
0 
-0.9 ± 
0.1 
0.00
1 
GS5989
10 
0 0 b LinJ26_V3.1670Sphingolipid delta-4 desaturase, putative 
(dTPS22) 
N.D.  
Lin24E1
0* 
-
1.8
0 
-0.8 ± 
0.3 
0.03
8 
GS5989
11 
0 0 b LinJ22_V3.1310I/6 autoantigen-like protein (dTPS0) + 
-6.7 ± 0.9 
Lin27B2 -
1.8
0 
-0.8 ± 
0.3 
0.03
4 
GS5989
12 
0 - c LinJ35_V3.1230Short chain dehydrogenase, putative (dTPS1, 
dTPS7) 
+ 
-3.2 ± 0.7 
Lin28C5 -
1.8
1 
-0.9 ± 
0.1 
0.00
5 
GS5989
13 
0 2e-
154 
b LinJ26_V3.167 Sphingolipid delta-4 desaturase, putative 
(dTPS22) 
N.D.  
Lin31H9
* 
-
1.9
4 
-1.0 ± 
0.1 
0.00
6 
GS5989
14 
0 0 b LinJ26_V3.1000Dynein heavy chain, putative (dTPS0) + 
-6.2 ± 0.8 
Lin36A9
* 
-
2.1
5 
-1.1 ± 
0.2 
0.00
9 
GS5989
15 
0 0 b LinJ26_V3.1000Dynein heavy chain, putative (dTPS0) + 
-6.2 ± 0.8 
Lin40G1
2* 
-
1.9
2 
-0.9 ± 
0.2 
0.01
3 
GS5989
16 
2e-
161 
0 b LinJ23_V3.1560Lathosterol oxidase-like protein (dTPS28, 
dTPS30) 
+ 
-14.3 ± 
1.7 
LinJ06_V3.1330Coproporphyrinogen III oxidase, putative 
(dTPS33) 
+ 
-5.8 ± 0.1 Lin47D8 -
4.0
0 
-2.0 ± 
0.5 
0.02
3 
GS5989
17 
0 0 a 
LinJ06_V3.1340Protoporphyrinogen oxidase-like protein (dTPS13, 
dTPS32) 
+ 
-2.2 ± 0.4 
Lin49B7 -
4.3
8 
-2.1 ± 
0.0 
0.00
0 
GS5989
18 
0 4e-
64 
a LinJ34_V3.4160Phosphatidylinositol-3-kinase (tor2)-like 
protein (dTPS0) 
N.D.  
LinJ28_V3.23802,3-bisphosphoglycerate-independent 
phosphoglycerate mutase-like protein (dTPS9, 
dTPS35) 
+ 
-3.4 ± 0.3 Lin50H7 -
2.3
2 
-1.2 ± 
0.1 
0.00
5 
GS5989
19 
 
7e-
164 
0 b 
LinJ28_V3.2390Cyclin dependent kinase-binding protein, putative 
(dTPS0) 
+ 
-127.4 ± 
7.4 
Lin60B1
* 
-
3.8
4 
-1.9 ± 
0.1 
0.00
1 
GS5989
20 
0 0 c LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 
Lin60E5 -
1.8
0 
-0.8 ± 
0.3 
0.03
5 
GS5989
21 
0 0 b LinJ26_V3.0970Hypothetical protein, conserved/HPB (dTPS5, 
dTPS16) 
N.D
. 
 
LinJ36_V3.6550Glucose transporter lmgt2, putative (dTPS47) + -8.1 ± 1.1 Lin63F3 -
2.9
5 
-1.6 ± 
0.4 
0.01
8 
GS5989
22 
0 0 b 
LinJ36_V3.6560Glucose transporter, putative (dTPS47) + -6.3 ± 1.4 
LinJ36_V3.6550Glucose transporter lmgt2, putative (dTPS47) + -8.1 ± 1.1 Lin66F1
0 
-
2.1
8 
-1.1 ± 
0.0 
0.00
0 
GS5989
23 
 
0 0 b 
LinJ36_V3.6560Glucose transporter, putative (dTPS47) + -6.3 ± 1.4 
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Lin80B3 -
2.0
6 
-1.0 ± 
0.3 
0.02
4 
GS5989
24 
0 0 b LinJ28_V3.3250Glucose-6-phosphate-N-acetyltransferase, putative 
(dTPS46) 
N.D.  
Lin82C6 -
1.7
4  
-0.8 ± 
0.3 
0.03
8 
GS5989
25 
0 - c LinJ31_V3.0440Cysteine peptidase, Clan CA, family C2, putative 
(dTPS0) 
+ 
-3.3 ± 0.1 
LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 Lin84E8 -
2.2
6 
-1.2 ±  
0.2 
0.00
7 
GS5989
26 
 
0 0 a 
LinJ31_V3.23803’-nucleotidase/nuclease precursor,  putative 
(dTPS4, dTPS29) 
+ 
-2.7 ± 0.6 
Lin86H3 -
2.1
7 
-1.1 ± 
0.1 
0.00
4 
GS5989
27 
0 8e-
130 
b LinJ31_V3.0950Sodium stibogluconate-resistance protein, putative 
(dTPS) 
N.D.  
LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 
LinJ31_V3.23803’nucleotidase/nuclease precursor, putative 
(dTPS4, dTPS29) 
+ 
-2.7 ± 0.6 
Lin89F9 -
2.9
3 
-1.6 ± 
0.4 
0.02
6 
GS5989
28 
0 0 b 
LinJ31_V3.2390Helicase-like protein N.D.  
LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 Lin92D7
* 
-
2.2
7 
-1.2 ± 
0.2 
0.00
5 
GS5989
29 
0 0 b 
LinJ31_V3.23803’-nucleotidase/nuclease precursor, putative 
(dTPS4, dTPS29) 
+ 
-2.7 ± 0.6 
LinJ06_V3.1320Pteridine transporter, putative (dTPS0) + -2.1 ± 0.3 Lin92G9 -
2.2
9 
-1.2 ± 
0.1 
0.00
4 
GS5989
30 
0 0 a 
LinJ06_V3.1330Coproporphyrinogen III oxidase, putative 
(dTPS33) 
+ 
-5.8 ± 0.1 
Lin97D1 -
11.5
7 
-3.5 ± 
0.2 
0.00
1 
GS5989
31 
0 0 a LinJ06_V3.1320Pteridine transporter, putative (dTPS0) + -2.1 ± 0.3 
Lin97F6 -
1.8
0 
-0.8 ± 
0.3 
0.02
9 
GS5989
32 
0 0 b LinJ26_V3.0460Hypothetical protein, conserved N.D.  
LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 Lin98C7
* 
-
2.1
2  
-1.1 ± 
0.5 
0.04
4 
GS5989
33 
0 0 b 
LinJ31_V3.23803’nucleotidase/nuclease precursor, putative 
(dTPS4, dTPS29) 
+ 
-2.7 ± 0.6 
Lin98F9 -
2.43  
-1.3 ± 
0.3 
0.01
6 
GS5989
34 
2e-
190 
1e-
101 
b LinJ32_V3.3120Minichromosome maintenance (MMC) complex 
subunit, putative (dTPS8, dTPS38, dTPS48) 
N.D.  
Lin98G1
0* 
-
2.1
3 
-1.1 ± 
0.2 
0.01
5 
GS5989
35 
0 0 b LinJ30_V3.2780Superoxide dismutase, putative (dTPS0) + -3.7 ± 0.1 
Lin101B
5 
-
2.6
2 
-1.4 ± 
0.3 
0.01
1 
GS5989
36 
0 0 b LinJ09_V3.0650Serine peptidase family S51, peptidase E, 
putative (dTPS19) 
N.D.  
Lin105A
3 
-
2.2
2 
-1.1 ± 
0.1 
0.00
5 
GS5989
37 
0 0 b LinJ36_V3.1320Fructose-1,6-bisphosphate aldolase (dTPS37) N.D.  
Lin105B
9 
-
6.1
3 
-2.6 ± 
0.2 
0.00
1 
GS5989
38 
0 0 a LinJ06_V3.1320Pteridine transporter, putative (dTPS0) + -2.1 ± 0.3 
LinJ06_V3.1330Coproporphyrinogen III oxidase, putative 
(dTPS33) 
+ 
-5.8 ± 0.1 Lin109F
4 
-
3.1
6 
-1.7 ± 
0.5 
0.02
4 
GS5989
39 
0 0 a 
LinJ06_V3.1340Protoporphyrinogen oxidase-like protein (dTPS13, 
dTPS32) 
+ 
-2.2 ± 0.4 
Lin111C
2 
-
3.1
4 
-1.7 ± 
0.1 
0.00
1 
GS5989
40 
0 0 b LinJ09_V3.0650Serine peptidase family S51, peptidase E, 
putative (dTPS19) 
N.D.  
Lin111F
3 
-
2.0
9 
-1.1 ± 
0.4 
0.03
5 
GS5989
41 
0 0 a LinJ31_V3.2210Prostaglandin F2α synthetase (dTPS31) N.D.  
Lin125H
5 
-
1.9
5 
-1.0 ± 
0.2 
0.02
2 
GS5989
42 
0 0 b LinJ36_V3.1590Serine/threonine protein kinase, putative (dTPS43) N.D.  
Lin144F
11 
-
2.2
8 
-1.2 ± 
0.1 
0.00
4 
GS5989
43 
0 0 a LinJ31_V3.2210Prostaglandin F2α synthetase (dTPS31) N.D.  
LinJ22_V3.1300Cyclophilin, putative (dTPS0) + 
-4.1 ± 0.6 Lin144H
10 
-
1.8
5 
-0.9 ± 
0.1 
0.00
7 
GS5989
44 
0 0 a 
LinJ19_V3.1310I/6-autoantigen-like protein (dTPS0) N.D.  
Lin144H
11 
-
2.3
2 
-1.2 ± 
0.1 
0.00
3 
GS5989
45 
0 0 b LinJ36_V3.2700Membrane-bound acid phosphatase precursor 
(dTPS42) 
N.D.  
Lin150E
4 
-
1.8
6 
-0.9 ± 
0.4 
0.04
8 
GS5989
46 
0 0 b LinJ13_V3.1060Calmodulin, putative (dTPS16) N.D.  
Lin153D
1 
-
1.8
0 
-0.8 ± 
0.1 
0.00
2 
GS5989
47 
0 0 b LinJ27_V3.0530Amino acid permease, putative (dTPS26) N.D.  
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Lin155H
12 
-
2.5
2 
-1.3 ± 
0.4 
0.02
4 
GS5989
48 
0 0 a LinJ36_V3.0250Peptidyl-prolyl cis-trans isomerase, putative 
(dTPS18, dTPS25) 
N.D.  
Lin157D
8 
-
2.7
8 
-1.5 ± 
0.2 
0.00
5 
GS5989
49 
0 0 b LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 
Lin158A
10 
-
2.4
0 
-1.3 ± 
0.2 
0.00
8 
GS5989
50 
0 0 b LinJ23_V3.0870Hypothetical protein, conserved  N.D
. 
 
LinJ16_V3.0600Histone H3, putative (dTPS8) N.D.  Lin177E
10 
-
1.7
2 
-0.8 ± 
0.3 
0.04
2 
GS5989
51 
7e-
167 
0 b 
LinJ16_V3.0610Histone H3, putative (dTPS8) N.D.  
LinJ25_V3.0740Eukaryotic initiation factor 5a, putative 
(dTPS15) 
N.D.  Lin182F
2 
-
2.1
8 
-1.1 ± 
0.3 
0.02
2 
GS5989
52 
0 0 b 
LinJ25_V3.0750Eukaryotic initiation factor 5a, putative 
(dTPS15) 
N.D.  
Lin187C
10 
-
4.0
2 
-2.0 ± 
0.3 
0.00
3 
GS5989
53 
0 0 b LinJ06_V3.1320Pteridine transporter, putative (dTPS0) + -2.1 ± 0.3 
Lin193E
6 
-
2.0
0 
-1.0 ± 
0.4 
0.04
0 
GS5989
54 
0 0 b LinJ23_V3.1230SHERP (dTPS0) N.D.  
Lin194A
4 
-
1.7
0 
-0.8 ± 
0.2 
0.01
6 
GS5989
55 
0 1e-
11 
b LinJ22_V3.1270Aquaporin, putative (dTPS3) N.D.  
LinJ07_V3.0150Acyl-CoA dehydrogenase, mitochondrial 
precursor, putative (dTPS21, dTPS27) 
+ 
-2.4 ± 0.2 Lin197D
2* 
-
3.3
2 
-1.7 ± 
0.3 
0.00
7 
GS5989
56 
0 0 b 
LinJ07_V3.0170Maoc family protein - 
-1.1 ± 0.3 
Lin206C
10* 
-
1.9
9 
-1.0 ± 
0.3 
0.03
2 
GS5989
57 
6e-69 1e-
82 
b LinJ07_V3.0940Cytochrome b5-like protein (dTPS0) + 
-1.7 ± 0.0 
Lin206H
7* 
-
1.9
0 
-0.9 ± 
0.2 
0.01
5 
GS5989
58 
0 0 b LinJ31_V3.1240Vacuolar-type proton translocating 
pyrophosphatase 1, putative (dTPS0) 
+ 
-3.4 ± 0.7 
Lin208F
2* 
-
2.1
0 
-1.1 ± 
0.3 
0.02
6 
GS5989
59 
2e-86 3e-
64 
b LinJ31_V3.1240Vacuolar-type proton-translocating 
pyrophosphatase 1, putative  
+ 
-3.4 ± 0.7 
LinJ18_V3.1070Cysteine peptidase, Clan CA, family C2, putative 
(dTPS0) 
+ 
-3.3 ± 0.1 Lin208H
10 
-
2.6
8 
-1.4 ± 
0.4 
0.01
0 
GS5989
60 
0 0 a 
LinJ18_V3.1080Vacuolar protein sorting complex subunit, putative 
(dTPS 0) 
- 
-1.2 ± 0.3 
Lin219A
10* 
-
1.8
9 
-0.9 ± 
0.1 
0.00
4 
GS5989
61 
0 0 b LinJ19_V3.0710Glycosomal malate dehydrogenase (dTPS1, 
dTPS30) 
+ 
-2.3 ± 0.0 
Lin228D
4* 
-
1.8
6 
-0.9 ± 
0.2 
0.01
4 
GS5989
62 
0 0 a LinJ19_V3.0090Fibrillarin, putative (dTPS0) + 
-4.1 ± 0.8 
LinJ06_V3.1320Pteridine transporter, putative (dTPS0) + -2.1 ± 0.3 Lin229E
6 
-
9.6
3 
-3.3 ± 
0.2 
0.00
2 
GS5989
63 
0 0 a 
LinJ06_V3.1330Coproporphyrinogen III oxidase, putative 
(dTPS33) 
+ 
-5.8 ± 0.1 
LinJ31_V3.1240Vacuolar-type proton translocating 
pyrophosphatase 1, putative (dTPS0) 
+  Lin231G
4 
-
1.7
3 
-0.8 ± 
0.2 
0.01
3 
GS5989
64 
0 0 b 
LinJ31_V3.1250Hypothetical protein, unknown function N.D.  
Lin234C
9 
-
1.7
7 
-0.8 ± 
0.3 
0.03
8 
GS5989
65 
0 0 b LinJ20_V3.1220Cysteine peptidase, Clan CA, family C2, putative 
(dTPS41) 
+ 
-3.3 ± 0.1 
LinJ31_V3.23703’-nucleotidase/nuclease, putative (dTPS4, 
dTPS29) 
+ 
-4.6 ± 0.4 Lin242E
2 
-
2.8
5 
-1.5 ± 
0.4 
0.02
5 
GS5989
66 
0 0 b 
LinJ31_V3.23803’-nucleotidase/nuclease precursor, putative 
(dTPS4, dTPS29) 
+ 
-2.7 ± 0.6 
Lin252B
11 
-
2.1
2 
-1.1 ± 
0.3 
0.02
8 
GS5989
67 
0 0 b LinJ17_V3.170/
200 
Elongation factor 1α (dTPS14, dTPS39, dTPS44) N.D.  
Lin265E
2 
-
1.8
9 
-0.9 ±  
0.3 
0.04
2 
GS5989
68 
1e-
165 
0 b LinJ29_V3.1880Paraflagellar rod protein 1D, putative (dTPS0) N.D.  
Lin270H
10* 
-
1.9
6 
-1.0 ± 
0.2 
0.01
0 
GS5989
69 
0 0 b LinJ31_V3.1150Monoglyceride lipase, putative (dTPS0) + 
-1.9 ± 0.0 
Lin271C
2* 
-
1.9 
-0.9 ± 
0.3 
0.04
3 
GS5989
70 
0 0 b LinJ28_V3.0090Adenylate cyclase-like protein (dTPS9, dTPS12, 
dTPS23, dTPS24) 
+ 
-2.3 ± 0.0 
LinJ36_V3.6550Glucose transporter lmgt2, putative (dTPS47) + -8.1 ± 1.1 Lin285H
1 
-
2.1
2 
-1.1 ± 
0.2 
0.01
2 
GS5989
71 
0 0 b 
LinJ36_V3.6560Glucose transporter, putative (dTPS47) + -6.3 ± 1.4 
LinJ31_V3.1640Dipthine synthase, putative -  Lin294G
4* 
-
2.0
0 
-1.0 ± 
0.2 
0.01
3 
GS5989
72 
0 0 b 
LinJ31_V3.1660Putative 3-ketoacyl-CoA thiolase-like protein 
(dTPS0) 
+ 
-3.6 ± 0.5 
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This table contains clones that map against down-regulated genes (not hypothetical or 
unknown) with the combined effect of temperature increase and pH decrease (TPS). The 
features described are: clone number; F; base-two logarithmic scale F and SD values; p; 
GenBank GSS accession numbers; e-values; Def. according to mapping outcomes a, b or c (see 
brief explanation in the text); Id.; annotated gene function (codes for Additional file 4: Figure 
S4,);  qRT-PCR. When a given clone overlaps with more than one annotation, stage-specific 
regulation is only demonstrated if the qRT-PCR result is positive (+). The asterisk indicates 
that the clone contains more gene sequences that have not been checked by qRT-PCR. Genes in 
bold are also down-regulated under TS. 
 
Table 3. Up-regulated genes after temperature increase up to 37 ºC (day 4) in L. infantum.  
e-value qRT-PCR Clone F Log2F ±  
SD 
p GenBank 
GSS Fw Rv 
Def. Id. Annotated Gene Function  
+/- F ± SD 
Lin11D
7 
2.37 1.2 ± 0.1 0.00
4 
GS59885
4 
- 0 c LinJ31_V3.
0460 
Amastin, putative + 4.7 ± 
1.2 
Lin17C
6 
1.92 0.9 ±  
0.1 
0.00
6 
GS59897
3 
0 0 b LinJ36_V3.0
640 
Delta-8 fatty acid desaturase-like protein N.D.  
LinJ08_V3.
0680 
Amastin-like protein N.D.  Lin19D
1 
1.88 0.9 ± 0.3 0.02
8 
GS59885
5 
 
3e-
18 
0 b 
LinJ08_V3.
0690 
Amastin-like protein N.D.  
Lin33G
2 
2.29 1.2 ± 0.8 0.04
6 
GS59885
7 
6e-
118 
6e-
118 
b LinJ34_V3.
4370 
Amastin-like surface protein, putative N.D.  
Lin70F5 2.03 1.0 ± 0.4 0.04
5 
GS59897
4 
0 0 b LinJ36_V3.7
290 
Delta-8 fatty acid desaturase-like protein N.D.  
Lin77H
8 
2.89 1.5 ± 0.4 0.02
2 
GS59897
5 
3e-
175 
0 b LinJ08_V3.
0690 
Amastin-like protein N.D.  
Lin86H
7 
2.03 1.0 ± 0.2 0.00
5 
GS59886
7 
0 2e-
101 
b LinJ08_V3.
0700 
Amastin-like protein + 6.8 ± 
0.9 
Lin87H
2 
1.89 0.9 ± 0.1 0.00
7 
GS59886
8 
3e-
15 
3e-
33 
b LinJ08_V3.
0690 
Amastin-like protein N.D.  
Lin89D
9 
1.70 0.8 ± 0.3 0.04
0 
GS59886
9 
0 0 b LinJ21_V3.
0770 
ATP-binding cassette sub-family E, 
putative 
N.D.  
LinJ30_V3.
0640 
Ribosome biogenesis regulatoy protein 
(RRS1), putative 
+ 1.9 ± 
0.2 
LinJ30_V3.0
650 
Histidyl-tRNA synthetase, putative N.D.  
Lin90B
6 
1.95 1.0 ± 0.3 0.03
2 
GS59897
6 
0 0 a 
LinJ30_V3.0
660 
Hypothetical protein, conserved N.D.  
Lin91B
12 
1.75 0.8 ± 0.1 0.00
3 
GS59887
2 
0 0 b LinJ34_V3.
2660 
Amastin-like surface protein N.D.  
Lin100
B2 
1.84 0.9 ± 0.3 0.03
4 
GS59897
7 
0 9e-
27 
b LinJ27_V3.2
500 
Glycosomal phosphoenolpyruvate 
carboxykinase 
N.D.  
Lin104
B11 
1.77 0.8 ± 0.2 0.02
2 
GS59897
8 
0 0 b LinJ04_V3.0
570 
Spermidine synthase 1, putative N.D.  
Lin104
C10 
1.82 0.9 ± 0.2 0.01
5 
GS59897
9 
0 0 b LinJ08_V3.
1320 
Amastin-like protein N.D.  
LinJ06_V3.1
200 
Hypothetical protein, conserved N.D.  Lin106
A1 
2.43 1.3 ± 0.0 0.00
0 
GS59898
0 
0 0 c 
LinJ31_V3.
0590 
Amino acid transporter aATP11, putative + 2.4 ± 
0.3 
Lin109
B3 
1.89 0.9 ±  
0.2 
0.02
4 
GS59898
1 
0 0 b LinJ21_V3.2
130 
Centromere/microtubule binding protein 
(cbf5), putative 
N.D.  
LinJ14_V3.
1440 
Pteridine transporter + 2.5 ± 
0.3 
Lin113
C3 
2.99 1.6 ± 0.3 0.01
0 
GS59887
6 
3e-
74 
0 a 
LinJ14_V3.
1450 
Myo-inositol-1-phosphate synthase + 4.2 ± 
0.1 
LinJ24_V3.1
230 
Hypothetical protein, conserved N.D.  Lin137
A10 
1.98 1.0 ± 0.3 0.03
9 
GS59898
2 
0 0 b 
LinJ24_V3.
1240 
Translation factor SUI1, putative + 
 1.8 ± 
0.1 
Lin146E
3 
2.52 1.3 ± 0.3 0.04
3 
GS59888
2 
0 0 b LinJ31_V3.
0590 
Amino acid transporter aATP11, putative + 2.4 ± 
0.3 
LinJ14_V3.1
430 
Hypothetical protein, conserved N.D.  
LinJ14_V3.
1440 
Pteridine transporter + 2.5 ± 
0.3 
Lin162E
6 
1.92 0.9 ±  
0.3 
0.04
4 
GS59898
3 
0 0 a 
LinJ14_V3.
1450 
Myo-inositol-1-phosphate synthase + 4.2 ± 
0.1 
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LinJ22_V3.0
670 
Hypothetical protein N.D.  Lin168
A2 
1.87 0.9 ± 0.2 0.01
7 
GS59898
4 
1e-
78 
0 b 
LinJ22_V3.
0680 
3’a2rel-related protein + 3.5 ± 
0.6 
Lin175
D6 
2.20 1.2 ± 0.4 0.02
3 
GS59898
5 
0 0 b LinJ31_V3.
0460 
Amastin, putative + 4.7 ± 
1.2 
Lin185
A10 
2.04 1.0 ± 0.3 0.03
6 
GS59898
6 
0 0 a LinJ28_V3.0
620 
MAP kinase, putative N.D.  
Lin185
D7 
1.75 0.0 ± 0.2 0.02
0 
GS59898
7 
2e-
161 
0 b LinJ17_V3.0
200 
Elongation factor 1-alpha N.D.  
Lin188
H2 
3.20 1.7 ± 0.6 0.04
2 
GS59898
8 
0 0 c LinJ08_V3.
0680 
Amastin-like protein N.D.  
Lin194E
2 
1.79 0.8 ± 0.2 0.02
5 
GS59898
9 
- 0 c LinJ08_V3.
0710 
Amastin-like protein + 6.8 ± 
0.9 
Lin206
B6 
2.08 1.0 ± 0.3 0.03
5 
GS59899
0 
7e-
19 
0 b LinJ22_V3.
0680 
3’a2rel-related protein + 3.5 ± 
0.6 
LinJ17_V3.0
170   
Elongation factor 1-alpha N.D.   
Lin207A
1 
1.84 0.9 ± 0.2 0.01
5 
GS59899
1 
0 0 b 
LinJ17_V3.0
180 
Elongation factor 1-alpha N.D.  
Lin210
C4 
1.71 1.8 ± 0.1 0.03
0 
GS59889
3 
0 0 b LinJ08_V3.
0690 
Amastin-like protein N.D.  
Lin224
G2 
1.70 0.8 ± 0.2 0.01
4 
GS59889
5 
0 0 b LinJ08_V3.
0720 
Amastin-like protein N.D.  
Lin235
G8 
2.20 1.1 ± 0.2 0.00
2 
GS59889
6 
0 0 b LinJ08_V3.
1320 
Amastin-like protein N.D.  
Lin245E
2 
2.05 1.0 ± 0.3 0.03
2 
GS59889
7 
0 0 b LinJ22_V3.
0680 
3’a2rel-related protein + 3.5 ± 
0.6 
LinJ08_V3.
0680 
Amastin-like protein N.D.  Lin274
G6 
1.84 0.9 ± 0.2 0.01
2 
GS59899
2 
 
0  0 b 
LinJ08_V3.
0690  
Amastin-like protein N.D.  
Lin275
A8 
2.10 1.1 ± 0.1 0.00
3 
GS59890
0 
0 4e-
168 
b LinJ08_V3.
0720 
Amastin-like protein N.D.  
Lin282
B6 
2.08 1.0 ± 0.4 0.04
2 
GS59899
3 
0 0 b LinJ03_V3.0
960 
Elongation initiation factor 2 alpha subunit, 
putative 
N.D.  
Lin294
A11 
1.72 0.8 ± 0.1 0.00
1 
GS59890
2 
0 0 b LinJ08_V3.
1320 
Amastin-like protein N.D.  
Lin295
D9 
2.99 1.6 ± 0.4 0.02
0 
GS59890
3 
0 0 b LinJ34_V3.
1720 
Amastin-like surface protein, putative N.D.  
This table describes clones that contain up-regulated genes under the sole influence of 
temperature increase (TS) that do not map with hypothetical or unknown genes. The features 
described are: clone number; fold change (F); base-two logarithmic scale F and standard 
deviation (SD) values; p-value (p); GenBank GSS accession numbers; e-values of forward 
(Fw) and reverse (Rv) end mappings against BLAST; clone definition (Def.) according to 
mapping outcomes a, b or c (see brief explanation in the text); GeneDB identifiers (Id.), the 
corresponding annotated gene functions; qRT-PCR results. When a given clone overlaps with 
more than one annotation, stage-specific regulation is only demonstrated if the qRT-PCR result 
is positive (+). Genes in bold are also up-regulated under TPS. 
 
 
Table 4. Down-regulated genes after temperature increase up to 37 ºC (day 4) in L. infantum.  
e-value qRT-PCR Clone F Log2F ±  
SD 
p GenBank 
GSS Fw Rv 
Def. Id. Annotated Gene Function  
+/- F ± SD 
Lin9E5 -
1.77 
-0.8 ± 
0.3 
0.03
3 
GS59899
4 
4e-
131 
0 b  LinJ35_V3.1
150 
Oligosaccharyl transferase-like protein N.D.  
Lin40G
12 
-
1.97 
-1.0 ± 
0.2 
0.00
8 
GS59891
6 
2e-
161 
0 b LinJ23_V3.1
550 
Hypothetical protein, unknown function N.D.  
        LinJ23_V3.
1560 
Lathosterol oxidase-like protein + 5.0 ± 
0.7 
Lin49B
7 
-
4.38 
-2.1 ± 
0.0 
0.00
0 
GS59899
5 
0 4e-
64 
a LinJ34_V3.
4160 
Phosphatidylinositol-3-kinase (tor2)-like 
protein 
N.D.  
Lin 
60B1 
-
2.41 
-1.3 ± 
0.4 
0.02
5 
GS59899
6 
0 4e-
162 
c LinJ36_V3.7
040 
Hypothetical protein, conserved N.D.  
        LinJ31_V3.
2370 
3’-nucleotidase/nuclease, putative + 7.2 ± 
1.0 
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LinJ36_V3.
6550 
Glucose transporter lmgt2,  putative + 6.1 ± 
0.8 
Lin63F3 -
2.23 
-1.2 ± 
0.4 
0.04
3 
GS59899
7 
0 0 a 
LinJ36_V3.
6560 
Glucose transporter,  putative + 6.1 ± 
0.8 
LinJ31_V3.
2370 
3’-nucleotidase/nuclease, putative + 7.2 ± 
1.0 
Lin84E8 -
2.26 
-1.2 ±  
0.2 
0.00
7 
GS59899
8 
0 0 a 
LinJ31_V3.
2380 
3’-nucleotidase/nuclease precursor,  
putative 
+ 7.2 ± 
1.0 
Lin85H
1 
-
1.74 
-0.8 ± 
0.2 
0.02
5 
GS59899
9 
1e-
57 
1e-
20 
b LinJ30_V3.3
440 
CAS/CSE importin domain protein, putative N.D.  
LinJ31_V3.
2370 
3’-nucleotidase/nuclease, putative + 7.2 ± 
1.0 
Lin93H
3 
-
2.26 
-1.2 ± 04 0.03
0 
GS59900
0 
0 0 a 
LinJ31_V3.
2380 
3’-nucleotidase/nuclease precursor,  
putative 
+ 7.2 ± 
1.0 
Lin97D
1 
-
3.41 
-1.7 ± 
0.3 
0.00
1 
GS59893
1 
0 0 a LinJ06_V3.
1320 
Pteridine transporter, putative + 2.3 ± 
0.3 
LinJ30_V3.2
770 
Hypothetical protein, conserved N.D.  Lin98G
10 
-
2.13 
-1.1 ± 
0.2 
0.01
5 
GS59900
1 
0 0 b 
LinJ30_V3.
2780 
Superoxide dismutase, putative + 3.7 ± 
0.0 
Lin111
C2 
-
2.74 
-1.5 ± 
0.1 
0.00
2 
GS59900
2 
0 0 a LinJ09_V3.
0650 
Serine peptidase family S51, peptidase E, 
putative 
N.D.  
Lin150E
4 
-
1.86 
-0.9 ± 
0.3 
0.03
6 
GS59900
3 
0 8e-
22 
b LinJ13_V3.
1060 
Calmodulin, putative N.D.  
Lin155
H12 
-
2.34 
-1.2 ± 
0.3 
0.01
8 
GS59900
4 
0 0 a LinJ36_V3.
0250 
Peptidyl-prolyl cis-trans isomerase, 
putative 
N.D.  
Lin157
D8 
-
2.27 
-1.2 ± 
0.1 
0.00
2 
GS59900
5 
0 - c LinJ31_V3.
2380 
3’-nucleotidase/nuclease precursor,  
putative 
+ 7.2 ± 
1.0 
Lin179
B4 
-
1.76 
-0.8 ± 
0.1 
0.00
4 
GS59900
6 
0 0 b LinJ07_V3.0
030 
LinJ07_V3.0
040 
LinJ07_V3.0
050 
LinJ07_V3.0
060 
Hypothetical protein, conserved 
 
Hypothetical protein, conserved 
 
Hypothetical protein, conserved 
 
Alpha-adaptin-like protein 
N.D. 
 
N.D. 
 
N.D. 
 
+ 
 
 
 
 
5.3 ± 
0.4 
LinJ25_V3.
0740 
Eukaryotic initiation factor 5a, putative N.D.  Lin182F
2 
-
2.23 
-1.2 ± 
0.1 
0.00
8 
GS59895
2 
0 0 b 
LinJ25_V3.
0750 
Eukaryotic initiation factor 5a, putative N.D.  
Lin187
C10 
-
4.72 
-2.2 ± 
0.4 
0.01
3 
GS59895
3 
0 0 b LinJ06_V3.
1320 
Pteridine transporter, putative + 2.3 ± 
0.3 
Lin204
A11 
-
1.76 
-0.8 ± 
0.3 
0.03
8 
GS59900
7 
- 1e-
165 
c LinJ09_V3.
0650 
Serine peptidase, family S51, peptidase E, 
putative 
N.D.  
Lin210
B7 
-
1.74 
-0.8 ± 
0.2 
0.01
6 
GS59900
8 
0 0 a LinJ32_V3.3
690 
LinJ32_V3.3
700 
DEAD/DEAH box helicase, putative 
 
Hypothetical protein, conserved 
+ 
 
N.D. 
3.3 ± 
0.8 
Lin229E
6 
-
3.30 
-1.7 ± 
0.3 
0.00
5 
GS59896
3 
0 0 a LinJ06_V3.
1320 
LinJ06_V3.
1330 
Pteridine transporter, putative 
 
Coproporphyrinogen III oxidase, putative 
+ 
 
+ 
2.3 ± 
0.3 
4.5 ± 
0.6 
Lin242E
2 
-
2.37 
-1.2 ± 
0.4 
0.03
9 
GS59900
9 
1e-
137 
0 a LinJ31_V3.
2370 
LinJ31_V3.
2380 
3’-nucleotidase/nuclease, putative 
 
3’-nucleotidase/nuclease precursor,  
putative 
+ 
 
+ 
7.2 ± 
1.0 
7.2 ± 
1.0 
Lin255E
12 
-
2.54 
-1.3 ±  
0.3 
0.01
1 
GS59901
0 
0 0 b LinJ28_V3.0
210 
Histone H2B variant N.D.  
This table contains clones that map against down-regulated genes (not hypothetical or unknown) with 
the single effect of temperature increase (TS). The features described are: clone number; F; base-two 
logarithmic scale F and SD values; p; GenBank GSS accession numbers; e-values; Def. according to 
mapping outcomes a, b or c (see brief explanation in the text); Id.; annotated gene function;  qRT-
PCR. When a given clone overlaps with more than one annotation, stage-specific regulation is only 
demonstrated if the qRT-PCR result is positive (+). Genes in bold are also down-regulated under TPS. 
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Table 5. Differentially regulated genes after pH4.5 treatment (day 4) in L. infantum.  
e-value qRT-PCR Clone F Log2F ±  
SD 
p GenBank 
GSS Fw Rv 
Def. Id. Annotated Gene Function  
+/- F ± SD 
LinJ24_V3.0
020 
Clathin coat assembly protein. putative + 7.6 ± 
0.4 
LinJ24_V3.0
030 
Hypothetical protein. conserved N.D.  
Lin9E8 2.03 1.0 ± 0.1 0.00
3 
GS59901
1 
0 0 a 
LinJ24_V3.0
040 
60S ribosomal protein L17. putative N.D.  
LinJ31_V3.0
860 
Triacylglycerol lipase-like protein N.D.  Lin10H
12 
2.26 1.2 ± 0.1 
 
0.00
1 
GS59901
2 
 
0 0 a 
LinJ31_V3.0
870 
Lipase precursor-like protein N.D.  
Lin21H
10 
2.46 1.3 ± 0.1 0.00
1 
GS59891
0 
0 0 b LinJ26_v3.1
670 
Sphingolipid delta-4 desaturase. putative N.D.  
Lin33G
5 
1.76 0.8 ± 0.0 0.00
0 
GS59901
3 
   LinJ27_V3.1
300 
60S acidic ribosomal protein. putative N.D.  
Lin37C
10 
2.74 1.5 ± 0.2 0.00
6 
GS59901
4 
0 0 b LinJ33_V3.0
280 
RNA binding  protein rggm. putative N.D.  
LinJ22_V3.1
360 
Hypothetical protein. unknown fuction N.D.  
LinJ22_V3.1
370 
60S ribosomal protein L14 N.D.  
Lin58C
1 
2.32 1.2 ± 0.2 
 
 
0.00
1 
GS59901
5 
0 0 b 
LinJ22_V3.1
380 
Dephospho-CoA kinase. Putative   + 
-2.9 ± 
0.3 
Lin63B
7 
1.83 0.9 ± 0.1 0.00
2 
GS59901
6 
1e-
100 
1e-
103 
b LinJ15_V3.1
200 
60S acidic ribosomal protein P2 N.D.  
LinJ22_V3.0
470 
Hypothetical protein. conserved N.D.  Lin66A
8 
2.28 1.2 ± 0.1 
 
0.00
6 
GS59901
7 
0 0 a 
LinJ22_V3.0
480 
Ubiquitin-conjugating enzyme-like protein + -3.1 ± 
0.8 
Lin80C
3 
3.15 1.7 ± 0.3 0.00
4 
GS59901
8 
0 0 b LinJ28_V3.3
250 
Glucose-6-phosphate N-acetyltransferase N.D.  
Lin 
95F10 
2.26 1.2 ± 0.1 0.00
2 
GS59901
9 
0 0 a LinJ28_V3.2
360 
Ribosomal protein S29. putative N.D.  
LinJ35_V3.333
0 
60S ribosomal protein L31.  putative N.D.  Lin100F
8 
2.12 1.1 ± 0.2 
 
0.00
7 
GS59902
0 
0 2e-
161 
b 
LinJ35_V3.334
0 
60S ribosomal protein L31. putative N.D.  
Lin107
C12 
2.90 1.5 ± 0.2 0.00
1 
GS59902
1 
7e-
130 
5e-
134 
a LinJ11_V3.118
0 
40S ribosomal protein S15a.  putative N.D.  
LinJ30_V3.3
770 
CPSF-domain protein. putative N.D.  
LinJ30_V3.3
780 
60S acidic ribosomal protein P2. putative N.D.  
Lin122
C5 
1.93 0.9 ± 0.1 
 
 
0.00
5 
GS59902
2 
0 0 b 
LinJ30_V3.3
790 
60S acidic ribosomal protein P2. putative N.D.  
LinJ29_V3.1
920 
40S ribosomal protein S15a. putative N.D.  Lin135F
6 
2.63 1.4 ± 0.3 
 
0.03
6 
GS59902
3 
0 0 b 
LinJ29_V3.1
930 
Hypothetical protein. conserved N.D.  
LinJ24_V3.1
230 
Hypothetical protein. conserved N.D.  Lin137
A10 
2.00 1.0 ± 0.2 
 
0.01
9 
GS59902
4 
0 0 b 
LinJ24_V3.1
240 
Translation factor SUI1. putative + -5.0 ± 
0.6 
Lin144F
11 
1.72 0.8 ± 0.2 0.03
2 
GS59902
5 
0 0 a LinJ31_V3.2
210 
Prostaglandin F2α synthetase N.D.  
Lin161
C9 
2.54 1.3 ± 0.1 0.00
3 
GS59902
6 
0 1e-
177 
b LinJ26_V3.1
670 
Sphingolipid delta-4 desaturase. putative N.D.  
LinJ22_V3.0
470 
Hypothetical protein. conserved N.D.  Lin162
A9 
1.97 1.0 ± 0.2 
 
0.02
4 
GS59902
7 
0 0 b 
LinJ22_V3.0
480 
Ubiquitin-conjugating enzyme-like protein + -3.1 ± 
0.8 
LinJ25_V3.0
740 
Eukaryotic initiation factor 5a. putative N.D.  Lin182F
2 
3.27 1.7 ± 0.2 
 
0.00
9 
GS59902
8 
0 0 b 
LinJ25_V3.0
750 
Eukaryotic initiation factor 5a. putative N.D.  
LinJ14_V3.1
340 
Hypothetical protein. unknown funcion N.D.  
LinJ14_V3. 
1350 
Ubiquitin/ribosomal protein S27a. putative + 
-4.8 ± 
0.4 
Lin200
H12 
2.54 1.3 ± 0.1 
 
 
0.00
5 
GS59902
9 
0 0 a 
LinJ14_V3.1
360 
Hypothetical protein. conserved N.D.  
Lin218E
3 
1.82 0.9 ± 0.1 0.00
1 
GS59903
0 
0 0 b LinJ31_V3.2
210 
Prostaglandin F2α synthase N.D.  
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LinJ28_V3.0
090 
Adenylate cyclase-like protein  + 
-3.5 ± 
0.6 
LinJ28_V3.0
100 
Hypothetical protein. conserved N.D.  
Lin247
D7 
2.41 1.3 ± 0.4 
 
 
0.01
8 
GS59903
1 
5e-
109 
0 a 
LinJ28_V3.0
110 
Proteasome beta 3 subunit. putative N.D.  
Lin254
A4 
1.93 0.9 ± 0.2 0.00
9 
GS59903
2 
0 0 b LinJ04_V3.1
250 
Actin N.D.  
Lin254
H7 
1.73 0.8 ± 0.1 0.00
4 
GS59903
3 
0 0 b LinJ04_V3.1
250 
Actin N.D.  
Lin261F
8 
2.84 1.5 ± 0.2 0.00
7 
GS59903
4 
0 0 b LinJ21_V3.1
310 
40S ribosomal protein S23. putative N.D.  
Lin266F
6 
1.79 0.8 ± 0.1 0.00
9 
GS59903
5 
0 0 b LinJ27_V3.0
300 
Acyl carrier protein. putative N.D.  
LinJ36_V3.0
580 
Hypothetical protein. conserved N.D.  
LinJ36_V3.0
590 
Ubiquitin-like protein. putative + 
-2.3 ± 
0.0 
Lin267
B9 
1.74 
 
0.8 ± 0.2 
 
0.01
0 
GS59903
6 
0 0 b 
LinJ36_V3.0
600 
Cdc2-related kinase N.D.  
Lin269
B5 
2.75 1.5 ± 0.2 0.00
2 
GS59903
7 
0 0 b LinJ29_V3.2
970 
40S ribosomal protein S19-like protein N.D.  
Lin282
B6 
2.44 1.3 ± 0.2 0.00
9 
GS59903
8 
0 0 a LinJ03_V3.0
960 
Elongation initiation factor 2α subunit. 
putative 
N.D.  
Lin290
G8 
1.80 0.8 ± 0.1 0.00
3 
GS59903
9 
0 0 a LinJ17_V3.1
520 
Otubain cysteine peptidase. Clan CA. family 
C65. putative 
N.D.  
Lin43G
10 
-
5.36 
-2.4 ±
0.3 
0.00
7 
GS59904
0 
0 0 c LinJ28_V3.3
060 
Heat-shock protein hsp70. putative + 
-2.1 ± 
0.2 
LinJ36_V3.3
170 
Exosome complex exonuclease RRP41. 
putative 
N.D.  
LinJ36_V3.3
180 
Clathrin coat assembly protein-like protein N.D.  
LinJ36_V3.3
190 
Pre-mRNA branch-site protein p14 + 
-4.7 ± 
2.3 
Lin130
C5 
-
4.71 
-2.2 ±
0.3 
0.04
1 
GS59904
1 
0 0 b 
LinJ36_V3.3
200 
Hypothetical protein. conserved N.D.  
Lin173E
11 
-
7.74 
-3.0 ±
0.4 
0.00
2 
GS59904
2 
6e-
44 
3e-
147 
b LinJ36_V3.2
280 
ER-golgi transport protein erv25 precursor. 
putative 
N.D.  
Lin177
H3 
-
5.08 
-2.3 ±
0.2 
0.00
1 
GS59904
3 
0 4e-
60 
b LinJ28_V3.3
060 
Heat shock protein hsp70. Putative + 
-2.1 ± 
0.2 
LinJ18_V3.0
830 
Periodic tryptophan protein 2-like protein - 1.4 ± 
0.4 
Lin197E
1 
-
2.53 
-1.3 ±
0.1 
0.00
7 
GS59904
4 
0 0 c 
LinJ23_V3.1
610 
Acetyltransferase-like protein + 
-2.1 ± 
0.2 
Lin228
H5 
-
7.90 
-3.0 ±
0.4 
0.01
2 
GS59904
5 
7e-
196 
0 b LinJ21_V3.0
310 
Hexokinase. Putative N.D.  
Lin281
H8 
-
2.01 
-1.0 ±
0.1 
0.00
1 
GS59904
6 
8e-
136 
2e-
102 
b LinJ35_V3.1
580 
Metacaspase. Putative N.D.  
Lihsp70 -
4.21 
-2.0 ±
0.2 
0.00
4 
XM001470292 - - - - L. infantum hsp70 – DNA microarray control 
spot 
+ 
-2.1 ± 
0.2 
Ldohsp7
0 
-
4.57 
-2.2 ±
0.1 
0.02
8 
- - - - - L. donovani hsp70 – DNA microarray control 
spot 
N.D.  
Lmahsp
70 
-
3.85 
-1.9 ±
0.2 
0.01
7 
- - - - - L. major hsp70 – DNA microarray control 
spot 
N.D.  
This table contains clones that map against up- and down-regulated genes (not hypothetical or 
unknown) under pH decrease (PS). The features described are: clone number; F; base-two 
logarithmic scale F and SD values; p; GenBank GSS accession numbers; e-values; Def. 
according to mapping outcomes a, b or c (see brief explanation in the text); Id.; annotated gene 
function; qRT-PCR. When a given clone overlaps with more than one annotation, stage-specific 
regulation is only demonstrated if the qRT-PCR result is positive (+). Genes in bold are also up-
regulated under TPS.
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ADDITIONAL FILES. 
 
Additional file 1.  
Title: Electropherograms of total RNA samples. 
Description of data: Figure S1. 18S, 23Sα and 23Sβ spikes, absence of DNA contamination and RNA 
degradation.  
 
Additional file 2.  
Title: Scatter plots of normalised and contrasted microarray hybridisation data. 
Description of data: Figure S2. Spots that fulfill criteria to be considered as differentially regulated are 
highlighted. 
 
Additional file 3. 
Title: Differentially regulated hypothetical and unknown genes and unresolved clones. 
Description of data: Additional file 3: Tables S1, S2, S3, S4, S5, S6, S7 and S8. Tables S7 and S8 
describe clones containing minicircle sequences. 
 
Additional file 4  
Title: DAGs (BLAST2GO output).  
Description of data: Figures. S3 and S4. GO codes for functions directly annotated on differentially 
regulated genes found in this study. Each GO code is associated to a custom code to find annotations 
on genes in Tables 1, 2, 3, 4 and 5. 
 
Additional file 5  
Title: 3’NT/Nase and GT alignments and oligonucleotides for qRT-PCR.  
Description of data: Figure S6 (GT and 3’NT/Nase alignments) and Additional file 3: Table S9 
(oligonucleotides for qRT-PCR). 
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Additional file 6 
Title: Fold change clusters of differentially regulated genes including clone names. 
Description of data: Figure S5. Supplementary information for Figure 4 identifying the profiles with 
the clone numbers. 
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